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Abstract: 
In-feed antibiotics increase animal performance primarily through modulation of the 
intestinal microbiota. However, the exact mechanism of action is not understood. 
Furthermore, a majority of research on intestinal microbiota has focused solely on the 
intestinal bacterial population with very little being known about smaller populations 
such as fungi. Deep sequencing of the internal transcribed spacer 2 (ITS2) region of 
fungal rRNA genes was utilized in two studies to characterize the biogeography of the 
chicken intestinal fungal community, the mycobiome, along the gastrointestinal tract of 
broiler chickens on days 28 and 42 and its possible shift in response to bacitracin 
methylene disalicylate (BMD), a commonly used in-feed antibiotic. Intestinal luminal 
contents were also collected from the duodenum, jejunum, ileum, and cecum at seven 
different time points throughout an entire production cycle to determine the succession of 
the mycobiome. The phyla Ascomycota and Basidiomycota were found to be 
predominant regardless of age or GI location. Genera commonly associated with feed 
ingredients or soil such as Microascus, Gibberella, Trichosporon, and Aspergillus were 
the most abundant. However, their abundance varied greatly between studies indicating a 
strong environmental influence. A clear succession of the cecal mycobiome was 
observed, in which specific fungal consortia moved down the intestinal tract as birds aged 
indicating that this population is transient in nature. Dietary supplementation of BMD at a 
subtherapeutic level of 55 mg/kg resulted in a decrease in the cecal fungal diversity. To 
further elucidate effect of antibiotics on cecal bacterial populations, broiler chicks were 
supplemented with or without one of five commonly used antibiotics for 14 days 
followed by deep sequencing of the V3-V4 region of the bacterial 16S rRNA gene. 
Although each antibiotic modulated the gut microbiota differently, the closer the 
antibacterial spectrum, the more similarly the microbiota is regulated with treatments 
classified as ionophores having the greatest effect. Importantly, all antibiotics had a 
strong tendency to enrich butyrate- and lactic acid-producing bacteria, while reducing 
bile salt hydrolase-producing bacteria, suggesting in-feed antibiotics improve animal 
growth performance through enhanced metabolism and utilization of dietary 
carbohydrates and lipids and improved energy harvest. 
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Subtherapeutic antibiotics have been routinely included in livestock diets to improve 
animal performance. However, a rise in antibiotic resistance linked to livestock use has led to a 
ban on antimicrobial use for growth promotion and a change in consumer preference towards 
antibiotic-free animal products. This has, therefore, created a need to develop effective antibiotic 
alternatives to ensure animal health and growth performance. 
The gastrointestinal (GI) tract is home to a unique ecosystem of microorganisms 
consisting of bacteria, fungi, viruses, archaea, and protozoa, and antibiotics are hypothesized to 
provide performance benefits through modulation of this ecosystem. These microbes play a vital 
role in host health and metabolism through their effects on feed digestion, nutrient absorption, 
vitamin synthesis, and immune system development. To date, the majority of research has 
focused solely on the bacterial population, referred to as the microbiota. Its composition, as well 
as spatial and temporal changes, have been elucidated in several species. A link between the 
intestinal microbiota and growth performance of livestock animals has been established with 
studies showing strong correlations between specific bacterial taxa and weight gain. Furthermore, 
studies have shown the ability of specific antibiotics to modulate the intestinal microbiota, but 
with varying results.  
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Far less is currently known about the remaining microbial populations within the GI tract. 
Fungi in particular are known to account for less than 0.01% of the human fecal microbiota of 
humans, but are thought to account for a large proportion of the microbial biomass due to their size. 
Traditional culture dependent studies have identified yeast in the intestinal tracts of humans and 
animals with most focusing on the role of specific fungi in disease. With the advent of next-
generation sequencing technology, some have undertaken to characterize the fungal population, 
known as the mycobiome, in more detail. However, information is still scarce with the majority of it 
pertaining to humans.  
In this dissertation, we summarized the latest progress on the intestinal mycobiome of 
humans and livestock animals (Chapter II). We characterized the biogeography of the chicken 
intestinal mycobiome on day 28 and its response to a common antibiotic, bacitracin methylene 
disalicylate (BMD), using Illumina sequencing of the internal transcribed spacer 2 (ITS2) region of 
fungal rRNA genes (Chapter III). We revealed an obvious biogeographic difference in the mycobiota 
composition along the GI tract, with the crop, ventriculus, and duodenum being more diverse than the 
jejunum, ileum, cecum, and colon. The intestinal mycobiome was dominated by Ascomycota and 
Basidiomycota, with three genera including Microascus, Trichosporon, and Aspergillus accounting 
for over 83% of the total fungal population in any given segment, except for the duodenum, which 
harbored the most diverse fungal community. Antibiotic supplementation at 55 mg/kg was shown to 
decrease cecal diversity on day 14.   
A second study was further conducted to characterize the biogeography of the mycobiome at 
the market age, day 42 (Chapter IV). Additionally, luminal contents were collected from four GI 
locations (duodenum, jejunum, ileum, and cecum) at seven time points throughout an entire 
production cycle (days 3, 7, 14, 21, 27, 35, and 42) to evaluate the succession of the mycobiome. 
Diversity was once again shown to be highest in the upper GI tract. However, an age effect was 
observed as the jejunum displayed the greatest diversity on day 42. The genera Gibberella was the 
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most abundant in this study regardless of age or GI location, followed by Aspergillus and Candida. 
Evaluation of the fungal composition at the feature level revealed a clear passage of four fungal 
consortia down the GI tract as birds aged. In total, these results revealed the chicken intestinal 
mycobiome to be transient in nature and highly influenced by the environment.  
A third study was conducted to better understand the effect of antibiotics on intestinal 
microbes (Chapter V). Broiler chicks were raised for 14 days and supplemented with or without one 
of five commonly used antibiotics including three classical antibiotics (bacitracin methylene 
disalicylate, tylosin, and virginiamycin) and two ionophores (monensin and salinomycin) that differ 
in antimicrobial spectrum and mechanisms. Illumina sequencing of the V3-V4 region of the bacterial 
16S rRNA gene revealed each treatment to modulate the gut microbiota differently with ionophores 
having the strongest effect. Importantly, all treatments had a strong tendency to enrich butyrate- and 
lactic acid-producing bacteria, while reducing bile salt hydrolase-producing bacteria, suggesting 
enhanced metabolism and utilization of dietary carbohydrates and lipids and improved energy 
harvest. 
Collectively, we have comprehensively characterized the biogeography and succession of the 
chicken intestinal mycobiota throughout one entire production cycle, and its response to BMD. 
Furthermore, we have added to the knowledge regarding the effect of antibiotics on intestinal 
microbiota showing antibiotic-specific modulation of cecal bacteria. This data lays the foundation for 
future work investigating the potential of intestinal microbiota manipulation as a novel strategy to 






REVIEW OF LITERATURE 
 
COMPOSITION AND MODULATION OF THE INTESTINAL MYCOBIOME OF HUMANS 





The rise in antibiotic resistance in recent years has led to a ban on the use of medically important 
antibiotics in livestock diets. Additionally, consumer preference has shifted to a preference for 
antibiotic free products creating an urgent need for effective antibiotic alternatives. As 
subtherapeutic antibiotics are widely considered to improve animal performance through 
modulation of the intestinal microbiota, extensive work has been accomplished regarding 
characterization of the bacterial communities of humans and livestock and their response to 
antibiotic supplementation. However, very little is known regarding the smaller microbial 
populations including fungi, viruses, archaea, and protozoa. Fungi in particular are known to 
assist in the breakdown of dietary fiber and stimulate host immune function. This makes them an 
intriguing target for future research focused on antibiotic mechanism of action and the discovery 
of novel probiotics. However, overgrowth of several species is known to be pathogenic indicating 
a delicate balance within the intestinal ecosystem. In this review we summarized recent research 
regarding composition of the intestinal fungal population, known as the mycobiome, of humans, 
mice, and livestock animals as well its modulation by diet and antibiotic supplementation. While 
work in this area is increasing, very little has utilized advanced sequencing technology to 
comprehensively evaluate fungal communities. We believe that modulation of the intestinal 
mycobiota may be a novel alternative to antibiotics. However, additional work using deep 
sequencing technology is first needed to characterize the mycobiome in different species.  
 







Subtherapeutic antibiotics were first discovered to improve growth in livestock animals in the 
1940’s (1) and subsequently became common additives of livestock diets to improve production 
performance (2, 3). However, increased microbial resistance linked to antibiotic use in food 
animals has led to a ban on antimicrobial growth promoters and a change in consumer preference 
towards products from animals raised without antibiotics (2, 4, 5). This has, therefore, created a 
need to develop antibiotic alternatives to ensure animal health and growth performance. 
Antibiotics are hypothesized to improve animal performance through modulation of the 
intestinal microbiota (3, 6-9), which is a unique ecosystem consisting primarily of bacteria with 
smaller populations of fungi, viruses archaea, and protozoa. The intestinal microbiota plays a vital 
role in host health and metabolism through its effects on feed digestion, nutrient absorption, 
vitamin synthesis, and immune system development (10-12). To date, research has focused 
almost exclusively on the bacterial portion of the intestinal microbiota with very little known 
regarding the smaller populations.  
 Fungi have been shown to account for less than 0.03% of the fecal microbiota of humans 
and are typically considered to be part of the “rare biosphere” (13). However, a typical fungal cell 
is >100 times larger than a bacterial cell and  make up a large portion of the microbial biomass 
(14). Overgrowth of fungal species such as Candida and Aspergillus is known to cause disease in 
humans with recent work associating fungal dysbiosis with intestinal and extra-intestinal diseases 
(14-16). Nevertheless, yeasts species such as Saccharomyces cerevisiae have been shown to be 
beneficial and are commonly used as probiotics for human and livestock applications (17-19). A 
better understanding of the fungal community, known as the mycobiome, lays the groundwork for 
future studies investigating modulation of this community to improve animal growth and health.  
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 The first step in understanding the mycobiome is characterization of its composition in 
different species. Here we provide a review of the current literature regarding the intestinal 
mycobiome of humans and livestock animals and its modulation by diet and antibiotic 
supplementation. While the phyla Ascomycota and Basidiomycota predominate, mycobiome 
composition varies dramatically between species with factors such as age and diet playing a 
significant role on composition in each specie. 
FUNGI IN HUMANS AND MICE 
The presence of fungi in the human intestinal tract was recorded as early as 1917 by H. W. 
Anderson (20). Culture studies have identified fungi in the stool of infants as early as 1 week old 
with Candida spp. being the primary member observed (21-23). More recent investigations using 
Illumina deep sequencing technology have expanded this knowledge by identifying Candida 
species such as C. parapsilosis, C. tropicalis, C. orthopsilosis, and C. albicans, as well as 
Saccharomyces cerevisiae, Cladosporium velox, Cryptococcus pseudolongus, Debaryomyces 
hansenii, and Rhodotorula mucilagnosa on the skin, oral cavity, and fecal samples of infants (24, 
25). The infant mycobiome was observed to be relatively stable over the first month of life (25) 
while sampling from 10 days of age to 2 years old revealed an increase in alpha diversity with age 
(24). Several species were found to overlap between the maternal and infant mycobiomes with 
offspring mycobiomes beginning to converge toward maternal patterns at 1 and 2 years of age 
(24).  
 In adults, mycobiome composition is known to vary by sampling location. Illumina ITS1 
sequencing of oral wash samples revealed the presence of 81 genera with Candida, Aspergillus, 
Cladosporium, Aureobasidium, Penicillium, Schizophyllum, Rhodotorula, and Gibberella being 
the most abundant (26-28). The stomach was originally thought to be incompatible with microbial 
growth due to the harsh environment. However, E. C. von Rosenvinge et al. (29) found between 
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19 and 81 genus-level fungal OTUs in the stomach of adults with Candida and Phialemonium 
being found in all samples. However, 77.5% of all sequences could not be classified indicating a 
need for better reference databases for this intestinal location (29).  
 An early culture-based study of the small intestine identified 26 and 20 species in the 
jejunum and ileum, respectively (30). Culture-independent studies of these sites are limited. 
However, a metatranscriptome analysis of two patients receiving an ileostomy revealed the 
presence of Candida and Saccharomyces (31) while 18S rDNA polymerase chain reaction 
denaturing gradient gel electrophoresis (PCR-DGGE) analysis of ileal effluent also identified 
Coccidioides, Kluyveromyces, Fusarium, Ajellomyces, Aspergillus, and Cryptococcus (32). The 
feces of humans harbors between 102 and 106 cfu/g of cultivable fungi (33). Culture-independent 
studies of the fecal mycobiome have revealed a high amount of inter- and intra-individual 
variation (13, 34-37). Nevertheless, the genera Candida and Saccharomyces were identified in 
every study with Malassezia, Aspergillus, Mucor, Penicillium, and Debayomyces also identified 
in multiple studies (13, 34-37). By following the fecal mycobiome of 147 volunteers across three 
timepoints, A. K. Nash et al. (34) identified three OTUs, namely S. cereisiae, M. restricta, and C. 
albicans, to be present at all sampling time points in 63.6 to 92.2% of volunteers. The authors 
speculated that they may represent a core mycobiome. However, additional work supporting the 
idea of a core mycobiome has not emerged.  
 As intestinal fungi are part of a larger ecosystem, a few studies have investigated the 
relationship between the relative abundance of bacteria and fungi in human feces. A. K. Nash et 
al. (34), found several positive and negative correlations with Rikenellaceae and Botrytis 
displaying the strongest positive correlation while the strongest negative correlation was between 
Penicillium and Faecalibacterium. Additional studies have revealed a positive correlation 
between Aspergillus and Bifidobacterium and a negative association between Candida and 
Bacteroides (35, 38). 
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 In mice, fungal load was shown to increase from the ileum to distal colon (39-41). While 
several of the same genera were identified in both mice and humans, the murine mycobiome 
appeared surprisingly different from that of humans. Oligonucleotide fingerprinting of rRNA 
genes (OFRG) analysis of restricted flora and specific pathogen free mice revealed high 
abundance of Monilinia, Acremonium, Alternaria, Fusarium, and Cryptococcus (40). More recent 
studies using next-generation sequencing revealed the presence of approximately 50 genera with 
over 97% of sequences belonging to only 10 species (39). While I. D. Iliev et al. (39) identified 
Candida, Saccharomyces, and Trichosporon in fecal samples (39),  additional studies revealed 
very low abundance of these genera with members of Wickerhamomyces, Debaryomyces, 
Aspergillus, and Penicillium being most dominant (41, 42).  
 The murine mycobiome was also observed to change drastically over time. S. Dollive et 
al. (42) revealed the fecal mycobiome to be highly diverse for the first eight days of the 
experiment with no genera being predominate. A bloom of Whickerhamomyces anomalus was 
observed on day 15 becoming the most abundant species until day 22 when fecal mycobiomes 
diverged by cage (42). Specifically, one cage returned to a heterogenous state while the other was 
dominanted by Debaryomyces hansenii on day 22 and Eurotiales spp. on day 75 (42).  
FUNGI IN LIVESTOCK ANIMALS 
Supplementation of livestock diets with yeast species has been shown to improve production 
performance (43-45). A few species have been found to be pathogenic with Candida, Aspergillus, 
and Fusarium being associated with abortions and disease in livestock (46-52). However, only a 
handful of studies provide information on mycobiome composition in healthy animals.   
RUMINANTS 
Anaerobic fungi were first detected in ruminant animals by C. G. Orpin (53) and considerable 
work has been accomplished since then to understand this community. Fungi have been detected 
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in the rumen of lambs as early as 8 days of age (54) but were not detected in dairy calves until 
after weaning (55). In both cases they were preceded by bacterial colonization (54, 55). 
Anaerobic fungi concentration is highest in the rumen and omasum with abundance decreasing in 
the small intestine before increasing again in the large intestine and feces (56). Studies using 
anaerobic fungi specific primers have found the genera Neocallimastix, Orpinomyces, Piromyces, 
and Caecomyces in the rumen of beef and dairy cattle (57-60). All four are part of the family 
Neocallimastigaceae which has been shown to strongly co-occur with Bacteroidales, Prevotella, 
Clostridia, and Lachnospiraceae in the rumen of dairy cattle (59). These fungi are efficient at 
degrading cellulose while displaying limited ability to degrade protein sources (61, 62). For this 
reason, anaerobic fungi are thought to be the first to attach to fibrous material and contribute 
more to the degradation of plant material than rumen bacteria (63, 64). 
 Sequencing of rumen content using universal fungal primers such as ITS or 18S has 
revealed the presence of aerobic fungi as well with approximately 200 fungal genera identified 
(65, 66). Anaerobic fungi were found to predominate the rumen of sheep, cattle, and deer from 
New Zealand (67), and were the only fungi identified in the feces and rumen of dairy cattle 
sampled from two weeks of age to the first lactation (55). The latter is contradictory to a study by 
A. N. Hristov et al. (65) who found Neocallimastix to account for less than 3.5% of rumen 
mycobiota in dairy cows. A more recent study found anaerobic Neocallimastigaceae along with 
Orpinomyces and Piromyces to be most abundant in Holstein cows fed a high fiber diet while an 
increase in aerobic fungi belonging to the phylum Ascomycota was observed following switch to 
high grain diet (66). The most abundant aerobic fungi observed in the rumen include 





While several studies have investigated the role of Aspergillus and Fusarium in poultry disease 
(49-52), few have sought to understand the commensal fungal population. In broilers, fungal 
burden has been found to range from 1.6 x 103 to 3.9 x 103 cfu/g digesta with load being lowest in 
the cecum followed by the proventriculus and jejunum (68). Candida has been most often 
identified by culture-dependent studies followed by Saccharomyces, Geotrichum, Trichosporon, 
and Rhodotorula (68-71). Contrary to these results, J. A. Byrd et al. (72) identified 88 fungal 
species from the ceca of broiler chickens with Aspergillus being the most frequently identified 
followed by Penicillium, Verticillium, and Sporidiobolus.  
 To date, only two studies have used culture-independent methods to investigate the 
poultry mycobiome. Using 454 Roche sequencing only two Cladosporium species were detected 
in the cecum of broilers fed unmedicated diet, although another 17 fungal species were detected 
in animals supplemented with essential oils (73). More recently, ITS2 deep-sequencing of the 
turkey ileum revealed Sarocladium kiliense to be most abundant followed by Candida, Dothidea, 
and Cladosporium species (74). While the same four genera were predominant over time, 
sequential sampling of birds from the same cage revealed an increase in ileal alpha diversity over 
time (74).  
PIGS 
Contrary to other species, pigs appear to harbor a distinct commensal mycobiome dominanted by 
Kazachstania slooffiae (75-81). While very little is known about this yeast, characterization of the 
cell contents revealed abundant concentrations of amino acids including aspartic acid, glutamic 
acid, alanine, valine, isoleucine, leucine, lysin, proline and tryptophan (82). Exogenous 
supplementation of K. slooffiae after weaning was associated with in an increase in short chain 
fatty acid production, primarily propionic and valeric acid, and increased bacterial diversity (78). 
Along with K. slooffiae, members of Pichia, Saccharyomyces, Trichosporon, and Cryptococcus 
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were identified by culture or PCR-DGGE (79-81), while Hyphopichia and Wallemia were 
identified as abundant using ITS2 deep sequencing (75).  
 Investigation of the fecal mycobiome as pigs age revealed a low fungal load and very 
little change in fungal composition from birth to weaning at 21 days of age (77). A dramatic shift 
was observed at weaning with diversity increasing and the predominate family Cladosporiaceae 
being replaced by Saccharomycetaceae (77). The community then remains stable through at least 
35 days of age (76, 77). It is interesting to note that the dominant species K. slooffiae is not 
observed until after weaning (75, 77, 78). One study investigating biogeography of the piglet 
mycobiome on day 39 found fungal diversity to be highest in the stomach before decreasing in 
the small intestine and increasing again in the colon (77). While four genera were found to be 
abundant across all gastrointestinal locations, beta diversity analysis found stomach and feces 
samples to cluster independently of the small intestine segments (77). 
 Similar to humans and dairy cattle, members of the porcine intestinal mycobiome have 
been shown to correlate with bacterial members. Using PCR-DGGE, total fecal yeast counts were 
positively correlated with Lactobacilli and negatively correlated with Enterobacteria (79). More 
recently, ITS2 sequencing revealed Kazachstanie to be positively correlated with several genera 
including Alloprevotella, Lactobacillus, Prevotella 9, and Subdoligranulum (75). The genera 
Aspergillus, Cladosporium, Hyphopichia, and Wallemia were negatively correlated with multiple 
bacterial species with the most notable association being the negative correlation between 
Aspergillus and short chain fatty acid producing bacteria (75).  
EFFECT OF DIET ON THE INTESTINAL MYCOBIOME 
Diet is observed to be a major driver of intestinal mycobiome composition regardless of species. 
Characterization of the human mycobiome in association with the Human Microbiome Project 
did not reveal any significant associations between mycboiota composition and the metadata 
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collected (34). This led the authors to speculate that factors such as diet, environment, daily 
cycles, and host genetics probably play a larger role in influencing fungal composition (34). In 
agreement with this, fecal mycobiomes of individuals on a vegetarian diet were dominated by 
Fusarium, Malassezia, Penicillium, and Aspergillus species with only low levels of Candida 
observed (37). Furthermore, fecal pellets of mice fed a high fat diet had a high abundance of C. 
albicans while S. cerevisiae was predominant in mice fed a normal diet (83).  
 As mentioned previously, switching dairy cattle from a high fiber to a high grain diet was 
associated with increased fungal diversity (66). Specifically an increase in aerobic fungi 
belonging to the phyla Ascomycota was observed which was associated with a concomitant 
decrease in anaerobic fungi (66) and decrease in anaerobic fungal diversity and load (57, 58, 60, 
84). This change in composition is most likely due to the introduction of new fungal species in 
high concentrate diets combined with a reduction in cellulose, a preferred substrate of anaerobic 
fungi.  
 In pigs, dietary modulation of the mycobiota is most strongly associated with weaning 
and the introduction of solid feed (77). However, supplementation of piglet diets with 
transgalacto-oligosaccharides post-weaning was able to increase fecal yeast burden as compared 
to piglets on a control diet or the control diet supplemented with fructos-oligosaccharides (85). 
Additionally, fungal burden increased in the digesta of growing pigs fed a fermented liquid diet 
versus a nonfermented liquid diet (86).  
MODULATION OF INTESTINAL MYCOBIOTA BY ANTIBIOTICS 
Sub-therapeutic antibiotic supplementation is known to improve performance of livestock 
animals with modulation of intestinal microbial communities being most often proposed as the 
mechanism of action (3, 6-9). The effect of antibiotics on the mycobiome, though, is still unclear. 
Evaluation of stomach fluid revealed a striking reduction in fungal richness in one patient taking 
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antibiotics (29). Conversely, diversity was shown to be higher in antibiotic induced remission of 
pouchitis and to decrease when patients were switched to a placebo or probiotic treatment (87). A 
similar increase in diversity was observed in. mice provided an antibiotic cocktail which further 
showed an ability of the mycobiota to return to normal following cessation of antibiotic treatment 
(42). 
 Only two studies have investigated the mycobiome of livestock animals in the presence 
of antibiotics. In cattle, supplementation of diets with either monensin or nisin reduced the total 
rumen fungal population in vitro (88). In turkeys, sub-therapeutic BMD supplementation had no 
effect on the ileal mycobiota (74). While it is unlikely that antibiotics attack intestinal fungi 
directly, their effects on the bacterial population could results in subsequent changes in the 
mycobiome. More work is needed in this area to fully elucidate the broader effects of antibiotics 
on the intestinal microbial populations as a whole.  
CONCLUSION 
While work has begun to be completed regarding the intestinal mycobiome, research on this 
population is currently scarce with large variations observed between studies. Traditional culture 
based studies often identified Candida as the most abundant species of humans and monogastric 
animals. However, application of next-generation sequencing technology has revealed mycobiota 
composition to be unique in each species. The observation that diet is a major driver of fungal 
composition, along with the lack of a “core mycobiome”, indicates that fungi may be transient in 
nature with very few capable of colonizing the intestinal tract. While some fungal species are 
currently used as probiotic supplements, it has yet to be determined if modulation of the 
community is a viable target for antibiotic alternatives. In total, more work is needed in this area 
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CHICKEN INTESTINAL MYCOBIOME: INITIAL CHARACTERIZATION AND ITS 







The gastrointestinal (GI) tract harbors a diverse population of microorganisms consisting of not 
only bacteria, but also fungi, viruses, archaea, and protozoa. While much work has been focused 
on the characterization of intestinal bacterial community, very little is known about the fungal 
community, or mycobiota, in different animal species and chickens in particular. Here we 
characterized the biogeography of the mycobiota along the GI tract of day-28 broiler chicks and 
further examined its possible shift in response to bacitracin methylene disalicylate (BMD), a 
commonly used in-feed antibiotic, through Illumina sequencing of the internal transcribed spacer 
2 (ITS2) region of fungal rRNA genes. We revealed an obvious biogeographic difference in the 
mycobiota composition along the GI tract, with the crop, ventriculus, and duodenum being more 
diverse than the jejunum, ileum, cecum, and colon. The intestinal mycobiome was dominated by 
Ascomycota and Basidiomycota, with three genera including Microascus, Trichosporon, and 
Aspergillus accounting for over 83% of the total fungal population in any given segment, except 
for the duodenum, which harbored the most diverse fungal community. We also observed an 
obvious shift of the cecal mycobiota between day-14 and day-28 broilers. Dietary 
supplementation of BMD at a subtherapeutic level of 55 mg/kg resulted in a significant decrease 
in the cecal fungal diversity. Taken together, we provided a comprehensive biogeographic view 
and maturation of the chicken intestinal mycobiota and its influence by an in-feed antibiotic. A 
better understanding of intestinal mycobiota may lead to development of novel strategies to 
improve poultry health and productivity. 
 






The intestinal tract is home to a diverse microbial population consisting primarily of bacteria with 
smaller populations of fungi, archaea, protozoa, and viruses (1, 2). To date, extensive work has 
been performed to characterize the intestinal bacterial community. Dysbiosis of gut microbiota is 
known to be associated with a variety of intestinal and extra-intestinal diseases (1, 2). However, 
very little is known about non-bacterial populations of the intestinal tract. Recently, increased 
work has been conducted to understand the fungal community of the human intestinal microbiota, 
known as the mycobiota, and its role in health and disease (3, 4). While large individual 
variations have been observed, human oral and intestinal fungi are known to belong primarily to 
the phyla Ascomycota and Basidiomycota, with genera such as Saccharomyces, Candida, 
Aspergillus, Cladosporium, Penicillium, Wallemia, Malassezia, Aureobasidium, and Epicoccum 
being most often observed (3-5). Although fungal species comprise fewer than 1% of the 
microorganisms in the human intestinal tract, recent work has demonstrated their ability to 
modulate the innate and adaptive immune systems (6-8). Fungal dysbiosis has been linked to 
multiple diseases such as inflammatory bowel disease, allergic airway disease, atopic dermatitis, 
and alcoholic liver disease (3, 4, 9). 
 To date, most of the mycobiota research have focused on humans and mice. Little is 
known regarding the intestinal mycobiota of livestock animals and nonruminants in particular. 
Ruminant mycobiome research has primarily focused on anaerobic fungi belonging to the phylum 
Neocallimastigomycota (10-14). First discovered in the rumen of sheep (15), anaerobic fungi are 
thought to be the first to attach to fibrous material (16) and contribute more to the degradation of 
plan material than cellulolytic bacteria (17). In pigs, Kazachstania sloofiae is the most frequently 
detected species in weaned Landrace pigs in a culture-based study (18), whereas deep sequencing 
identified Kazachstania telluris as the dominant fungal species in a miniature breed of weaned 
pigs (19).  
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 In limited poultry mycobiome studies, all but one were culture-based and most were 
restricted only to the cecum (20-25). Candida or Aspergillus was revealed to be the predominant 
in the chicken cecum in culture-dependent studies. Surprisingly, the study that employed a 
culture-independent pyrosequencing approach only detected two Cladosporium species in the 
cecum of broilers fed unmedicated diet, although another 17 fungal species were detected in 
animals supplemented with essential oils (20). Therefore, we sought to comprehensively 
characterize the biogeography of the intestinal mycobiome of broiler chickens using Illumina 
deep sequencing of the luminal contents throughout the GI tract. We further investigated the 
maturation and the effect of subtherapeutic and therapeutic supplementation of bacitracin 
methylene disalicylate (BMD), an in-feed antibiotic, on the cecal mycobiome composition.  
MATERIALS AND METHODS 
Animal trial 
All animal trials were conducted in accordance with the Institutional Animal Care and Use 
Committee of Oklahoma State University under protocol number AG-173. Day-of-hatch male 
Cobb broiler chicks were obtained from Cobb-Ventress Hatchery (Siloam Springs, AR) and 
randomly assigned to one of three dietary treatments with 12 birds per cage and 6 cages per 
treatment. Birds were provided ad libitum access to feed and tap water for the entire duration of 
the trial. Dietary treatments included antibiotic-free standard corn-soybean starter mesh diet or 
the starter diet supplemented with BMD at subtherapeutic (55 mg/kg) or therapeutic (275 mg/kg) 
levels. Birds were raised on floor cages with fresh dry pine wood shavings under standard 
management in an environmentally controlled room with temperatures starting at 33oC and 
decreasing 3oC every 7 days. Lighting for this trial included the light to dark ratio of 23:1 from 
day 0 to 7, 16:8 from day 8 to 22, 17:7 on day 23, and 18:6 from day 24 to 28. To minimize 
cross-contamination, birds in different treatments were housed in separate rows with physical 
30 
 
barriers in between. On days 14 and 28, two birds per cage and 12 birds per treatment were 
euthanized via CO2 asphyxiation, and the cecal contents were collected to evaluate the effect of 
BMD on the cecal mycobiome. Additionally, the luminal contents were collected from different 
segments of the GI tract (crop, ventriculus, mid-duodenum, mid-jejunum, mid-ileum, cecum, 
colon, and cloaca) on day 28 from 12 control birds for characterization of the chicken intestinal 
mycobiome. The samples were immediately frozen in liquid nitrogen and stored at -80oC until 
further processing.  
DNA isolation and sequencing 
Microbial DNA was isolated from intestinal contents using the ZR Fecal 96-Well DNA Isolation 
Kit (Zymo Research, Irvine, CA) according to the manufacturer’s protocol. DNA quality and 
quantity were determined using Nanodrop ND-1000 and the absence of degradation was 
confirmed using agarose gel electrophoresis. High-quality DNA was shipped on dry ice to 
Novogene (Novogene, Beijing, CA) for next generation PE250 sequencing of the ITS2 gene 
using the ITS3 (GCATCGATGAAGAACGCAGC) and ITS4 (TCCTCCGCTTATTGATATGC) 
primers on an Illumina HiSeq platform. PCR amplification and library preparation were 
performed by Novogene using the NEBNext® Ultra™ DNA Library Prep Kit (New England 
Biolabs, Ipswich, MA).  
Bioinformatic analysis and statistics 
Illumina paired-end reads were analyzed using the Deblur program (52) in Qiime2 (ver 2019.7) 
(53). Deblur is capable of achieving single-nucleotide resolution based on error profiles within 
samples and produces denoised sequences, known as amplicon sequence variants (ASVs) or exact 
sequence variants (ESVs) which can be compared between studies. Fungal sequences were 
processed using the ‘deblur denoise-other’ option with positive alignment-based filtering against 
the UNITE reference database. Denoised sequences were classified into fungal features using the 
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WARCUP v2 fungal ITS database and the Ribosomal Database Projects (RDP) Bayesian 
Classifier (54, 55). A bootstrap confidence of 80% was used for taxonomic classification. 
Features with a classification of less than 80% were assigned the name of the last confidently 
assigned level followed by “_unidentified”. Species classification of the top 20 OTUs was 
confirmed through BLASTN search of the nucleotide database of GenBank. Features appearing 
in less than 5% of samples were removed from downstream analysis. Data was normalized using 
cumulative sum scaling in the metagenomeSeq package of R (56). Analysis and visualization of 
the mycobiota composition was conducted in R version 3.5.1 (57). The α- and β-diversities were 
calculated with the phyloseq package version 1.24.2 (58). Plots were made using ggplot2 version 
3.0.0 (59).  
 Normality of the data was determined using Shapiro Wilks test in R. Significant 
differences in the α-diversity and the relative abundance were determined using Kruskal-Wallis 
and multiple comparisons were performed using pairwise Wilcoxon Rank Sums test. The α-
diversity was calculated using Shannon Index and Observed OTUs. Results were plotted using 
box and whisker plots, in which the middle line denotes the median value and the lower and 
upper hinges represent the first and third quartiles, respectively. Whiskers extend from the hinge 
to the highest or lowest value no farther than 1.5× the inter-quartile range. Points outside of this 
range are considered outliers. The β-diversity was calculated using the Bray-Curtis and Jaccard 
indices as dissimilarity measures of diversity and richness, respectively. Significant differences 
were determined using ANOSIM in mothur (60).  
Accession number  






Biogeography of the chicken intestinal mycobiota  
Male Cobb broiler chicks were fed an antibiotic-free, non-medicated diet under standard 
management as recommended by Cobb-Vantress (Siloam Springs, AR). To characterize the 
biogeography of intestinal mycobiota, luminal contents were obtained from eight different 
segments of the GI tract (crop, ventriculus, duodenum, jejunum, ileum, cecum, colon, and cloaca) 
of 12 heathy chickens on day 28. Microbial DNA was isolated and sequenced on an Illumina 
HiSeq using the internal transcribed spacer 2 (ITS2) chemistry. Following quality control, 
31,148,538 high-quality sequencing reads were obtained with an average of 249,188 sequences 
per sample. Sequences were denoised using deblur and rare reads were removed resulting in 
identification of 648 features at the single-nucleotide resolution.  
The α-diversity of the intestinal mycobiota was determined using Shannon Index (Fig. 
1A), Number of Observed Features (Fig. 1B), and Pielou’s Evenness Index (Fig. 1C), 
respectively. All metrics revealed a significant difference in the α-diversity across the GI tract. 
Interestingly, the mycobiome in the crop, ventriculus, and duodenum displayed the highest levels 
of richness, evenness, and diversity. A sharp decrease in Shannon diversity was observed the 
jejunum and ileum, while the lowest α-diversity was observed in the cecum. The overall α-
diversity was increased slightly in the colon and cloaca, both of which also display larger 
variations among individual animals. A similar trend was observed for richness with cecum and 
colon displaying the least number of features per sample. Evenness also followed a pattern 
similar to that of the Shannon index and richness measurements. However, jejunum and ileum 
were shown to have the least balanced communities followed by a slight increase in evenness in 
the cecum, colon, and cloaca.  
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 To measure the difference in the mycobiota composition among the GI locations, β-
diversity analysis was performed using the Bray-Curtis and Jaccard indices. ANOSIM analysis 
revealed a significant difference in the β-diversity for both metrics (P < 0.001) with R values of 
0.418 and 0.461 for the Bray-Curtis and Jaccard indices, respectively. Visualization of the Bray-
Curtis distance matrix using PCoA analysis revealed a tendency to form three clusters (Fig. 2A). 
The first was dominated by the crop, colon, and cloaca, while the second and third were 
comprised of ileum and cecum, respectively. Greater individual variations in the mycobiota 
composition were observed for the ventriculus, duodenum, and jejunum. Similar results were 
seen with the Jaccard index (Fig. 2B), with the exception of a tendency for the ventriculus 
samples to cluster with the ileum, while the jejunal samples clustered with the cecum. Pairwise 
comparisons revealed a significant difference in almost all comparisons regardless of index 
(Supplementary Table 1). However, it should be noted that R values for significant comparisons 
range from 0.088 to 0.874, indicating that some significant p-values do not reflect a true 
difference in composition.  
To further evaluate the mycobiota composition of day-28 broiler chickens, the relative 
abundance was calculated at both the phylum and feature levels (Fig. 3). Ascomycota and 
Basidiomycota were two most dominant phyla throughout the entire GI tract, representing 89-
99.9% of the total fungal population in any given segment (Fig. 3A). While Ascomycota 
accounted for 72.6-88.0% of the fungi, Basidiomycota amounted to 11.7-27.4% (Data not 
shown). Zygomycota and Glomeromycota were two minor phyla detected at an average of less 
than 0.1% in each GI location, and approximately 0.02% fungi failed to be classified. 
Collectively, the minor phyla and unidentified Fungi were denoted as “Others” (Fig. 3A).   
Gut mycobiota appeared to be rather limited in diversity, with top 20 features accounting 
for 66.8-96.3% of total fungal population in any given intestinal segment (Supplementary Table 
2). In fact, all of the top 20 features were represented by members of the Microascus, 
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Trichosporon, and Aspergillus genera. A BLAST search of the GenBank database further 
confirmed that eleven of the top 20 features showed a 97 – 99% identity to the Microascus 
member Scopulariopsis brevicaulis, while all four Trichosporon features showed a 97-100% 
identity to T. asahii. Due to the high resolution of the deblur algorithm, it is very likely that these 
features represent several strains of one species or several closely related species in the GI tract. 
Out of five Aspergillus species, F3, F10, F15, and F20 are 99-100% identical to several related 
species of Aspergillus, while F13 is 99-100% identical to A. versicolor (Supplementary Table 2). 
All of these top 20 features, showed a differential enrichment in different segments of the GI tract 
(Supplementary Table 2). Furthermore, many of the highly homologous features were enriched 
differently. For example, the relative abundance of S. brevicaulis F2, F5, and F8 varied greatly 
throughout the GI tract. While S. brevicaulis F12 and F17 were most abundantly colonized in the 
crop, colon and cloaca, S. brevicaulis F4 and F7 were found to consistently be absent from the 
ileum and cecum (Supplementary Table 2). 
Maturation of the cecal mycobiome 
Previous work in poultry has demonstrated a maturation of the cecal bacteriome as birds age (26-
28). To evaluate developmental succession of the mycobiota, the cecal contents were collected 
from 12 healthy male Cobb broiler chickens at 14 and 28 days of age and analyzed for their 
mycobiota compositions. No significant difference was observed for either the Shannon Index 
(Fig. 4A), Observed Features (Fig. 4B), or Pielou’s Evenness Index (Fig. 4C). A large inter-
individual variation appeared to be present on day 14 versus day 28. This was especially true for 
sample richness. Additionally, β-diversity analysis revealed a significant separation between day 
14 and day 28 for the Bray-Curtis (Fig. 5A) index, although ANOSIM analysis revealed the 
separation to be weak, as indicated by R = 0.267. Similar to α-diversity, the Jaccard (Fig. 5B) 
index found no difference in richness between day 14 and day 28.  
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Compositionally, the cecal mycobiome did appear to undergo a substantial change in 
composition. This was most clearly seen by a strong increase in Ascomycota, and subsequent 
decrease in Basidiomycota, abundance on day 28 relative to day 14 (Fig. 6A). Relative abundance 
of fungal features revealed two Trichosporon asahii features (F1 and F9) to dominate every 
sample on day 14 followed by members of Scopulariopsis brevicaulis (F8 and F11) and 
Aspergillus sp. (F3 and F15) (Fig. 6B). An increase in three S. brevicaulis features (F8, F11, and 
F21) was observed on day 21 along with an increase in the Aspergillus feature F3. Statistical 
analysis on the top 20 features using Kruskal-Wallis test did not reveal any significant differences 
at FDR £ 0.05 (Supplementary Table 3).  
Effect of BMD on the cecal mycobiome 
A number of studies have demonstrated the ability of antibiotics to modulate the chicken 
intestinal bacterial community (29-32). To determine the potential effect of antibiotics on 
intestinal mycobiome, day-of-hatch male Cobb chicks were fed unmedicated feed or feed 
supplemented with either a subtherapeutic (55 mg/kg) or therapeutic level (275 mg/kg) of BMD, 
a commonly used in-feed antibiotic, continuously for 14 days, followed by analysis of the cecal 
contents from 12 chickens in each of the three groups. Although we failed to observe any 
significance difference in growth performance of chickens (data not shown), the α-diversity 
analysis of the cecal mycobiome revealed a significant decrease in both the diversity and richness 
in response to BMD (Fig. 7). The Shannon index revealed a decrease in overall diversity in 
response to both doses of BMD. However, the shift was only found to be significant for the 
subtherapeutic group. Cecal richness appeared to dose dependently increase in response to BMD 
with the therapeutic group being significantly greater than both control and subtherapeutic BMD. 
A similar trend to the Shannon Index was observed for community evenness with no significant 
difference between groups (Fig. 7C). It should be noted that a high degree of variation in all 
indices was observed for both the control and therapeutic BMD groups. The β-diversity analysis 
36 
 
revealed a significant difference in the mycobiome composition as measured by both overall 
diversity (P < 0.001, R = 0.269) (Fig. 8A) and richness (P = 0.001, R = 0.448) (Fig. 8B). Both 
indices revealed two distinct clusters with both doses of BMD clustering largely separately from 
the controls. Pairwise comparisons revealed a significant difference between all three groups for 
the Jaccard index with the strongest difference observed between control and BMD55 (R = 0.570) 
(Supplementary Table 4). For the Bray-Curtis index, both doses of BMD were significantly 
different from control but not different from one another.  
 Investigation of the relative abundance of different fungal phyla in the chicken cecum 
revealed no significant difference (FDR > 0.05) in either the Basidiomycota or Ascomycota 
populations in response to BMD. Basidiomycota accounted for 69.1 – 81.5% of all fungi while 
Ascomycota relative abundance ranged from 18.5 – 30.8% (Data not shown). Trichosporon, 
Aspergillus, and Microascus were the dominant genera regardless of age (Fig. 9A). An increase 
in Aspergillus was observed in response to BMD treatment at the expense of Microascus. A 
number of features were shown to be significantly regulated by BMD with closely related 
features being regulated differently (Fig. 9B). For example, both doses of BMD had a tendency 
(FDR = 0.068) to increase the abundance of T. asahii F1 from approximately 27% in the control 
group to 75% and 72% in the subtherapeutic and therapeutic groups, respectively. However, T. 
asahii F9 was completely abolished in both BMD groups while another T. asahii feature (F34) 
remained largely unchanged (Supplementary table 5).  Similar results were observed with S. 
brevicaulis features as F8, F11, and F21 disappeared in the presence of BMD while F2 and F5 
increased in a dose-dependent manner (Supplementary table 5). Additional features significantly 
affected by BMD included enrichment of an unidentified Aspergillus sp, F3, Aspergillus 
versicolor F13, and Debaryomyces hansenii F424, as well as depletion of Aspergillus sp F15, 





While extensive work has been performed in multiple animal species to characterize the intestinal 
bacterial population and its relationship with health and disease, very little is known about the 
intestinal mycobiota particularly in chickens. The fungal community is estimated to account for 
approximately 0.02% of the intestinal mucosa-associated microbiota and 0.03% of the fecal 
microbiota in humans, albeit with large variations among individuals (33). In humans and mice, 
members of Ascomycota and Basidiomycota predominate, with low abundance of Zygomycota 
and Chytridiomycota in the GI tract (3, 34). Culture-dependent studies have long identified 
members of the genus Candida to be prevalent in the human GI tract (3), while culture-
independent techniques have typically revealed the presence of less than 100 fungal genera, with 
Candida, Penicillium, Wallemia, Cladosporium, Cladosporium, and Saccharomyces being the 
most prevalent in the stools of healthy individuals (3, 4). To date, at least 50 different fungal 
genera have been identified in mice, with Candida, Saccharomyces, and Cladosporium being the 
most common (4). Next generation sequencing of swine gut mycobiota has revealed the presence 
of three phyla (Ascomycota, Basidiomycota, and Zygomycota) and 67 genera (19). The phylum 
Ascomycota accounts for more than 97% of the sequence reads, while Kazachstania, a genus of 
Ascomycota, is represented by over 78% of the sequences (19).  
Previous limited investigations into the poultry mycobiome have relied primarily on 
culture-based techniques. Using culture methods, most studies have reported fewer than 20 fungal 
species and Candida has been frequently described as the most abundant genus in the GI tract of 
chickens and turkeys, although dominant Candida species varies among different studies (21-24). 
Besides Candida, Trichosporon, Geotrichum, Rhodotorula, and Saccharomyces have been 
frequently isolated in chickens as well (21-23). However, one other culture-dependent study 
reported the identification of 88 fungal species from over 3,000 cecal samples of broiler and layer 
chickens, with Aspergillus, Penicillium, Verticillium, and Sporidiobolus being the top four genera 
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(25), whereas a culture-independent 454 pyrosequencing method only revealed two fungal 
species, Cladosporium sp. and Cladosporium sphaerospermum, in the cecum of broilers fed 
unmedicated diets (20), presumably due to a lack of the sequencing depth.  
In this study, we identified 659 unique fungal features in the chicken GI tract. Consistent 
with previous studies in chickens and other animal species, our Illumina deep sequencing 
revealed a high abundance of Ascomycota throughout the GI tract of broiler chickens, followed 
by Basidiomycota in day-28 broiler chickens. Both phyla account for 90-99% of all fungal 
populations in any segment of the GI tract. Among all classifiable fungi, Microascus, 
Trichosporon, Aspergillus, and Gibberella are the top four most abundant genera (data not 
shown). Clearly, because of the depth of our sequencing approach, we have significantly 
expanded the repertoire of the fungal community in the GI tract of chickens in this study. 
Using the deblur method of denoising in Qiime2, we were able to achieve single-
nucleotide resolution in differentiating fungal features. Suprisingly, we identified Microascus as 
the most dominant genus on day-28 with 11 of the top 20 features in the chicken GI tract 
belonging to S. brevicaulis. This is in sharp contrast to previous studies. Furthermore, we did not 
observe any Candida species in our study while others found it to be a major genus. Such 
apparent discrepancies between our and several previously published studies are likely due to the 
dietary, environmental, and technical differences among different studies. Most poultry studies 
relied on culture-based methods, which are known to be biased towards fast-growing and non-
fastidious species (3), which is not surprising why the Candida species are frequently observed. 
Additionally, it is well known that the microorganisms including fungi present in the diet and on 
the flooring and caging materials are also major contributors to the intestinal microbiota (35, 36). 
Furthermore, the age and genetic background of animals used in several studies could be 
different. Nevertheless, the remaining top features belong to the genera Trichosporon and 
Aspergillus, both of which have been reported in humans as well as in chickens (21-23).  
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It is noted that the top features in our study are most commonly associated with soil or 
cereal grains, so their presence in the GI tract of broiler chickens likely originated from feed 
ingredients or wood shavings used on the floor. For example, the most dominant Microascus 
member, S. brevicaulis, in our study is a saprophyte and commonly found in soil, plant litter, 
wood, dung, and animal remains (37). Other dominant Trichosporon and Aspergillus species are 
also ubiquitous in soil and commonly associated with decaying plants and food material (38-40), 
while Gibberella is most likely derived from the corn used in the feed as it often causes 
Gibberella ear rot, a fungal disease manifested by the red or pink color of the mold starting at the 
ear tip of corns (41). 
Although they are likely to originate from the diet or the surrounding environment, most 
of these fungi appear to be able to survive in the GI tract, because their abundance remains 
relatively stable throughout the GI tract. In fact, S. brevicaulis has genetic potential to degrade a 
large variety of plant substrates (42), while T. asahii can assimilate a large variety of carbon and 
nitrogen sources (38), which may contribute to their ability to survive and thrive in the poultry GI 
tract. Whether these dominant fungal species play a beneficial role to the host and how they 
interact with the host remain unknown. Further work is warranted to better understand the role of 
these intestinal fungi in nutrient digestion, gut health, and disease resistance of poultry. It is worth 
noting that many of the Microascus, Trichosporon, and Aspergillus species are considered 
opportunistic pathogens particularly in immunocompromised humans (38, 39, 43). Therefore, 
these dominant intestinal fungi need to be monitored for possible contamination in poultry meat, 
litter, aerosol, and processing plant in order to ensure food safety and the safety of personnel.   
Similar to the biography of animal intestinal bacteriome, different segments of the GI 
tract harbor rather a distinct fungal community in chickens. However, to our surprise, the upper 
GI tract (crop, ventriculus, and duodenum) hosts a more diverse mycobiota than the jejunum, 
ileum, and cecum. Specifically, the chicken duodenum exhibits the highest diversity, while the 
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cecum shows the least diversity in the fungal community. These observations are opposite to the 
intestinal bacteriome, which is the most abundant and diverse in the lower GI segments of 
chickens (44). However, our mycobiome results are consistent with a recent culture-based study 
showing that the fungal population is the lowest in the cecum of broiler chickens, relative to the 
jejunum and proventriculus, while layers have the highest fungal load in the cecum (21). In 
turkeys, 50% of all fungal strains were cultured from the crop, with 31% coming from the beak 
cavity and 19% from the cloaca (23). The biogeography of the intestinal mycobiota in humans 
remains elusive, but a direction comparison of fungal rRNA copy number among the ileum, 
cecum, and proximal and distal colon of mice showed a gradual increase in the fungal population 
along the GI tract (6). Apparently, additional larger-scale studies on the spatial distribution and 
absolute quantification of the fungal community in the GI tract of different animal species are 
warranted in order to derive a more definitive conclusion, given large variations in the mycobiota 
among individuals (45) and the paramount role of the diet and environment in shaping the 
intestinal microbial community (36).  
Intestinal bacterial community typically undergoes age-dependent succession and 
becomes more diversified and stabilized as animals mature (13, 26, 27). While a difference in 
bacterial composition was observed between day 14 and day 28 as measured by the Bray-Curtis 
index, no significant difference was seen in richnes or cecal alpha diversity. This is most likely 
due to the large variation observed on day 14. A numerical difference in fungal composition was 
observed as birds aged. In particular, day 28 was marked by an increase in Ascomycota, driven 
by S. brevicaulis features belonging to the Microascus genus, and a concomitant decrease in 
Basidiomycota, primarily T. asahii features. However, statistical analysis did not find any of 
these changes to be significant. Human fecal mycobiota compositions are obviously different 
among healthy individuals of different age groups (46). Specifically, an inverse relationship 
between the intestinal fungal α-diversity and age was observed in an earlier human study showing 
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that infants and children harbor more fungal species than adults (46). This is consistent with the 
numerical, though not statistically significant, decrease in the number of features observed on day 
28 versus day 14. Obviously, sampling beyond 28 days of age is needed to determine whether the 
chicken intestinal mycobiota could eventually reach the stability and “maturation” stage. 
Additionally, absolute quantification of the fungi throughout the GI tract of chickens of different 
ages is also warranted to assess temporal changes of the overall fungal abundance.  
Antibiotics are known to significantly alter gut microbiota of chickens (29-32) and other 
animal species including humans (47); however, its impact on the fungal community has not been 
extensively explored. BMD is a common in-feed antibiotic and a derivative of bacitracin that is 
mainly active against Gram-positive bacteria by interfering with the synthesis of peptidoglycan, a 
major bacterial cell wall component (48). In this study, subtherapeutic inclusion of BMD causes a 
significant decrease in the α-diversity of the chicken cecal mycobiota but has no effect on cecal 
richness, whereas a therapeutic dose of BMD surprisingly has no obvious impact on overall 
diversity but causes a significant increase in cecal richness. Additionally, both BMD doses induce 
an obvious shift in the cecal fungal community composition. An increase in the fecal fungal α-
diversity was observed in both humans and mice in response to antibiotic treatment (49, 50), 
although a decrease in fungal richness was seen in a human patient treated prophylactically with 
antibiotics (51). Additional studies on the temporal and spatial impact of antibiotics on the 
absolute and relative abundance of the intestinal mycobiota are warranted. 
In summary, we comprehensively studied the biogeography of the chicken intestinal 
mycobiota by deep sequencing and revealed by surprise that the upper GI tract harbors a more 
diverse fungal community than the lower GI tract. Furthermore, the chicken gut mycobiota is 
dominated only by a few major fungal species, showing a much reduced complexity and greater 
individual variations than the bacteriome. Similar to the gut bacteriome, the mycobiome 
undergoes a compositional shift as chickens age. Additionally, in-feed antibiotics are capable of 
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altering the fungal community structure, although it is currently unknown whether it is a direct or 
indirect effect. A better understanding of the intestinal mycobiome provides a foundation for 
future work into the relationship between the mycobiome and gut health and physiology in 
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Table 3.S1. Pairwise ANOSIM of Biogeography Beta Diversity Indices 
 Crop Ventriculus Duodenum Jejunum Ileum Cecum Colon Cloaca 


































































































































Table 3.S2. Biogeography of the mycobiota in the gastrointestinal tract of day-28 chickens 
Feature Crop Ventriculus Duodenum Jejunum Ileum Cecum Colon Cloaca P-value FDR 
S. brevicaulis_F2 0.00a 18.10b 7.20bd 6.22ad 38.95c 0.76ad 4.51ad 11.06ab <0.001 <0.001 
S. brevicaulis_F8 0.00a 0.00a 11.54bc 28.35cd 0.00a 36.55c 4.09ab 0.00a <0.001 <0.001 
T. asahii_F1 0.00a 6.62b 10.48bc 8.29ab 14.49c 9.35ab 0.63a 8.13ab <0.001 <0.001 
S. brevicaulis_F12 8.96a 0.00a 0.00a 0.00a 0.00a 0.00a 26.48b 22.29b <0.001 <0.001 
S. brevicaulis_F4 20.62a 13.76ab 2.73bc 3.22c 0.00c 0.00c 7.48bc 1.64bc <0.001 <0.001 
Aspergillus sp_F3 0.00a 13.19bc 5.66bd 4.70abd 17.53c 5.22ab 0.16ad 2.83ab <0.001 <0.001 
S. brevicaulis_F5 0.00a 14.85bd 5.07cd 2.82ac 16.74b 0.43ac 2.35ac 5.00acd <0.001 <0.001 
S. brevicaulis_F11 0.00c 0.00c 8.64ab 15.64a 0.00c 18.92a 1.41bc 0.00c <0.001 <0.001 
T. asahii_F6 19.23a 5.02b 2.42bc 0.75bc 0.00c 0.00c 2.86bc 4.31bc <0.001 <0.001 
S. brevicaulis_F7 12.91a 11.05ab 1.91bc 1.79bc 0.00c 0.00c 2.62bc 0.72bc <0.001 <0.001 
T. asahii_F9 0.00a 0.00a 6.13bc 3.43b 0.00a 17.87d 1.08ac 0.00a <0.001 <0.001 
T. asahii_F16 1.61a 0.00a 0.00a 0.00a 0.00a 0.00a 13.49b 11.47b <0.001 <0.001 
S. brevicaulis_F17 6.38ab 0.00a 0.00a 0.00a 0.00a 0.00a 10.91ab 9.13ab <0.001 <0.001 
A. sp_F10 14.19a 1.96b 0.17bc 5.32bc 0.00c 0.00c 0.93bc 1.64bc <0.001 <0.001 
A. sp_F20 0.72a 0.00a 0.00a 0.00a 0.00a 0.00a 9.88b 8.13b <0.001 <0.001 
A. sp_F15 0.00a 0.00a 1.90bd 10.09c 0.00a 2.42bc 1.00ad 0.00a <0.001 <0.001 
S. brevicaulis_F14 0.00a 2.12b 1.23bc 0.54ac 4.36d 0.07ac 0.30ac 1.41ab <0.001 <0.001 
S. brevicaulis_F21 0.00a 0.00a 1.53bd 3.40bc 0.00a 4.47c 0.25ad 0.00a <0.001 <0.001 
A. versicolor_F13 0.00a 1.70b 0.17a 0.89ab 4.20c 0.34a 0.29a 1.24ab <0.001 <0.001 
S. brevicaulis_F29 0.85ac 0.00a 0.00a 0.00a 0.00a 0.00a 2.98b 2.65bc <0.001 <0.001 
Note: Mean relative abundance (%) of the phylum, top 20 fungal features are shown, with 12 samples per 
intestinal segment. Statistical significance was determined using non-parametric Kruskal Wallis test and p 
values were corrected for multiple comparisons using the Benjamini-Hochberg correction. For columns 
with an FDR ≤  0.05, means were separated using pairwise Wilcoxon Rank Sums test. Columns not sharing 
a common superscript are considered significantly different (P < 0.05). It is noted that, among the top 20 




Table 3.S3. Maturation of the chicken cecal mycobiome 
 Day 14 Day 28 P-Value FDR 
T. asahii_F9 41.55 17.87 0.172 0.448 
S. brevicaulis_F8 6.98 36.55 0.003 0.261 
T. asahii_F1 26.95 9.35 0.232 0.452 
S. brevicaulis_F11 4.19 18.92 0.003 0.261 
Aspergillus sp._F3 3.21 5.22 0.473 0.598 
Aspergillus sp._F15 4.27 2.42 0.619 0.721 
S. brevicaulis_F21 0.60 4.47 0.003 0.261 
Stenocarpella maydis_F19 3.10 0.07 0.176 0.448 
S. maydis_F45 1.78 0.18 0.291 0.452 
A. versicolor_F33 0.45 1.11 0.015 0.448 
D. hansenii_F43 1.00 0.51 0.901 0.937 
S. brevicaulis_F2 0.29 0.76 0.381 0.514 
Cephaliophora sp. _F65 0.54 0.34 0.238 0.452 
A. versicolor_F13 0.29 0.34 0.339 0.461 
S. brevicaulis_F5 0.15 0.43 0.473 0.598 
Aspergillus sp. _F93 0.36 0.03 0.118 0.448 
Gibberella sp. _F44 0.37 0.02 0.265 0.452 
Aspergillus sp. _F27 0.31 0.00 0.059 0.448 
Gibberella sp. _F140 0.29 0.02 0.321 0.461 
T. asahii _F34 0.22 0.06 0.202 0.449 
Note: Mean relative abundance (%) of the phylum, top 20 fungal features are shown, with 12 samples per 
intestinal segment. Statistical significance was determined using non-parametric Kruskal Wallis test and p 
values were corrected for multiple comparisons using the Benjamini-Hochberg correction. For columns 
with an FDR ≤  0.05, means were separated using pairwise Wilcoxon Rank Sums test. Columns not sharing 












Table 3.S4. Pairwise ANOSIM of Beta Diversity Indices 
 Control BMD55 BMD275 
Control  < 0.001 (0.570) < 0.001 (0.392) 
BMD55 < 0.001 (0.365)  < 0.001 (0.369) 
BMD275 0.001 (0.386) 0.058 (0.088)  



















Table 3.S5. Effect of BMD on the chicken cecal mycobiome composition  
Features Control BMD55 BMD275 P-Value FDR 
T. asahii_F1 26.95 75.49 72.33 0.021 0.068 
T. asahii_F9 41.55a 0.00b 0.00b <0.001 0.002 
Aspergillus sp._F3 3.21a 10.04b 14.73b 0.004 0.034 
S. brevicaulis_F8 6.98a 0.00b 0.00b <0.001 0.002 
Stenocarpella maydis_F19 3.10 1.19 1.60 0.206 0.299 
T. asahii_F6 0.00 5.50 0.00 0.384 0.408 
Aspergillus sp._F15 4.27a 0.00b 0.00b <0.001 0.002 
S. brevicaulis_F11 4.19a 0.00b 0.00b <0.001 0.002 
S. brevicaulis_F2 0.29a 0.94b 2.50c <0.001 0.003 
S. brevicaulis_F5 0.15a 0.56b 1.82c <0.001 0.002 
A. versicolor_F13 0.29a 0.40a 1.83b 0.001 0.016 
D. hansenii_F24 0.22a 0.90b 1.07b 0.013 0.049 
Stenocarpella maydis_F45 1.78a 0.00b 0.00b <0.001 0.002 
D. hansenii_F43 1.00a 0.00b 0.00b <0.001 0.002 
T. asahii _F34 0.22 0.38 0.38 0.529 0.550 
Aspergillus sp._F10 0.00 0.92 0.00 0.384 0.408 
Aspergillus sp._F27 0.31 0.10 0.37 0.405 0.427 
D. hansenii_F28 0.00 0.66 0.00 0.384 0.408 
Gibberella sp. _F44 0.37 0.12 0.15 0.038 0.096 
S. brevicaulis_F21 0.60a 0.00b 0.00b <0.001 0.002 
Note: Mean relative abundance (%) of the phylum, top 20 fungal features are shown, with 12 samples per 
intestinal segment. Statistical significance was determined using non-parametric Kruskal Wallis test and p 
values were corrected for multiple comparisons using the Benjamini-Hochberg correction. For columns 
with an FDR ≤  0.05, means were separated using pairwise Wilcoxon Rank Sums test. Columns not sharing 
a common superscript are considered significantly different (P < 0.05). It is noted that, among the top 20 
features, only Trichosporon asahii  belongs to the phylum Basidiomycota, while all the remaining fungi 









Fig. 3.1. Variation in the α-diversity of the mycobiome along the gastrointestinal tract of 
day-28 chickens. Newly hatched chicks were fed an antibiotic-free diet for 28 days before the 
luminal content samples were collected from each gastrointestinal segment. The diversity and 
richness were calculated from 12 samples of each segment and indicated by the Shannon Index 
(A), Observed OTUs (B), and Pielou’s Evenness (C) respectively. Kruskal Wallis was performed, 
and the means were separated with pairwise Wilcoxon Rank Sums with the segments not sharing 




Fig. 3.2. Principal coordinate analysis (PCoA) of the mycobiome along the gastrointestinal 
tract of day-28 chickens. Newly hatched chicks were fed an antibiotic-free diet for 28 days 
before the luminal content samples were collected from each gastrointestinal segment. Each data 
point represents an individual sample. PCoA was calculated from 12 samples of each segment 
using Bray-Curtis (A) and the Jaccard indicews (B), respectively. Statistical significance was 




Fig. 3.3. The mycobiota composition in different segments of the gastrointestinal tract of 
day-28 chickens. Newly hatched chicks were fed an antibiotic-free diet for 28 days before the 
luminal content samples were collected from each gastrointestinal segment. The relative 
abundance of OTUs was used to determine the fungal composition at the genus (A) and feature 
(B) levels with 12 samples of each segment. Only the top 20 genera and features are shown, with 





Fig. 3.4. Changes in the α-diversity of the cecal mycobiome between day-14 and day-28 
chickens. Newly hatched chicks were fed an antibiotic-free diet before the cecal content samples 
were collected on days 14 and 28. The diversity and richness were calculated from 12 samples on 
each sampling day and indicated by the Shannon Index (A), Observed OTUs (B), and Pielou’s 





Fig. 3.5. Principal coordinate analysis (PCoA) of the cecal mycobiome in day-14 and day-28 
chickens. Newly hatched chicks were fed an antibiotic-free diet before the cecal content samples 
were collected on days 14 and 28. Each data point represents an individual sample. PCoA was 
calculated from 12 samples on each sampling day using Bray-Curtis (A) and the Jaccard indices 






Fig. 3.6. The mycobiota composition in the cecum of day-14 and day-28 chickens. Newly 
hatched chicks were fed an antibiotic-free diet before the cecal content samples were collected on 
days 14 and 28. The relative abundance of OTUs was used to determine the fungal composition at 
the genus (A) and feature (B) levels with 12 samples on each sampling day. Only the top 20 






Fig. 3.7. Effect of BMD on the α-diversity of the chicken cecal mycobiota. The cecal content 
samples were collected 14 days after day-of-hatch chickens were fed an antibiotic-free diet or the 
diet supplemented with 55 or 275 mg/kg of BMD. The diversity and richness were calculated 
from 12 samples in each treatment and indicated by the Shannon Index (A), Observed OTUs (B), 
and Pielou’s Evenness (C), respectively. Differences were determined using Kruskal Wallis and 
means were separated using Wilcoxon Rank Sums. Treatments not sharing a common superscript 





Fig. 3.8. Effect of BMD on the β-diversity of the chicken cecal mycobiota. The cecal content 
samples were collected 14 days after day-of-hatch chickens were fed an antibiotic-free diet or the 
diet supplemented with 55 or 275 mg/kg of BMD. Principal coordinate analysis (PCoA) was 
performed with 12 samples in each treatment using Bray-Curtis (A) and the Jaccard indices (B), 
respectively. Each data point represents an individual sample. Statistical significance was 




Fig. 3.9. Effect of BMD on the chicken cecal mycobiota composition. Cecal content samples 
were collected 14 days after day-of-hatch chickens were fed an antibiotic-free diet or the diet 
supplemented with 55 or 275 mg/kg of BMD. The relative abundance of each OTU was 











Extensive work has been accomplished in recent years to characterize the intestinal bacterial 
community and its association with health and disease. However, very little has been done to 
describe the smaller intestinal microbial communities such as fungi, viruses, archaea, and 
protozoa. Here we comprehensively characterized the biogeography of the intestinal mycobiota of 
day-42 broiler chickens and its succession over the entire production cycle. Combining Illumina 
sequencing of the internal transcribed spacer 2 (ITS2) region of fungal rRNA genes with absolute 
quantification of bacterial and fungal populations, we revealed significant spatial and temporal 
differences in the chicken intestinal mycobiota. The intestinal mycobiome was dominated by 
Ascomycota and Basidiomycota, representing over 98% of the data. Three genera commonly 
associated with corn and soil, Gibberella (30 – 87%), Aspergillus (0.5 – 16.6%), and Candida 
(0.8 – 14.2%), were found to be most abundant. Feature analysis revealed an obvious age-
dependent transition of four distinct fungal consortia along the GI tract. In total, these results 
reveal a highly transient fungal population shaped primarily by the environment.  











The intestinal bacterial community is known to be associated with multiple intestinal and extra-
intestinal diseases (1-6). However, less studies have been performed to investigate smaller 
microbial communities within the gastrointestinal (GI) tract, which include fungi, viruses, 
archaea, and protozoa. Recently, studies have been undertaken to understand the fungal portion of 
the human intestinal microbiota and its role in health and disease (7, 8).  
In humans, the fungal community, known as mycobiota, is estimated to account for 
approximately 0.02% of the intestinal mucosa-associated microbiota and 0.03% of the fecal 
microbiota (9). Investigations into the human oral and intestinal fungal residents have revealed 
the phyla Ascomycota and Basidiomycota to be dominant, and Saccharomyces, Candida, 
Aspergillus, Cladosporium, Penicillium, Wallemia, Malassezia, Aureobasidium, and Epicoccum 
are among the most common genera that have been identified (7, 8, 10). Fungal dysbiosis has 
been linked to multiple diseases such as inflammatory bowel disease, allergic airway disease, 
atopic dermatitis, and alcoholic liver disease (7, 8, 11). Although Ascomycota and Basidiomycota 
have also been identified as the major phyla in mice, Candida, Saccharomyces, Trichosporon, 
Aspergillus, Penicillium, Wickerhamomyces, Cladosporium, and Fusarium are among the top 
genera identified (12-15).  
In livestock animals, the mycobiome research has primarily focused on ruminant animals 
with special attention given to anaerobic fungi in the phylum Neocallimastigomycota (16-20). 
First discovered in the rumen of sheep (21), anaerobic fungi are thought to be the first to attach to 
fibrous material (22) and contribute more to the degradation of plan material than cellulolytic 
bacteria (23). A culture-based study with weaned Landrace pigs revealed Kazachstania sloofiae 
to be the most frequently detected species (24), whereas deep sequencing identified K. telluris as 
the dominant fungal species in a miniature breed of weaned pigs (25).  
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In limited poultry mycobiome studies, all but one were culture-based and most were 
restricted only to the cecum (26-31). Candida or Aspergillus was revealed to be the predominant 
in the chicken cecum in culture-dependent studies. Surprisingly, the study that employed a 
culture-independent pyrosequencing approach only detected two Cladosporium species in the 
cecum of broilers fed unmedicated diet, although another 17 fungal species were detected in 
animals supplemented with essential oils (26). Previous work in our lab used next generation 
Illumina sequencing to investigate the biogeography of the chicken intestinal mycobiome on day 
28. We revealed Microascus, Trichosporon, Aspergillus, and Gibberella to be the top four genera 
and revealed an obvious development-associated shift in the cecal mycobiome composition 
(unpublished). However, only two time points (day 14 and day 28) were included in the study 
making it difficult to fully determine any successional changes in mycobiome composition. Also, 
because of no obvious maturation pattern up to day 28, there is a need to expand the study to 
include the broiler chickens up to the market age (day 42-49). Therefore, we sought to expand our 
previous study by using Illumina deep sequencing of the luminal contents from four GI locations 
(duodenum, jejunum, ileum, and cecum) from day 3-42 to characterize the succession of the 
chicken mycobiome throughout the entire production cycle. Furthermore, we also sequenced the 
luminal contents throughout the GI tract of day-42 broilers to determine the biogeography of the 
chicken mycobiome at market age.  
MATERIALS AND METHODS 
Animal Trial 
An animal trial was conducted in accordance with the Institutional Animal Care and Use 
Committee of Oklahoma State University under protocol number AG-173. Day-of-hatch male 
Cobb broiler chicks were obtained from Cobb-Vantress (Siloam Springs, AR) and randomly 
assigned to 12 cages with 10 birds per cage and ad libitum access to feed and tap water for the 
entire duration of the trial. Birds were raised on floor cages with fresh dry pine wood shavings in 
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an environmentally controlled room with temperatures starting at 33oC and decreasing 3oC every 
7 days. Lighting included the light to dark ratio of 23:1 from day 0 to 7 and 16:8 from day 8 to 
42. Non-medicated starter, grower, and finisher diets were formulated to meet or exceed NRC 
recommendation with no in-feed antibiotics or coccidiostat. Diet was switched from starter to 
grower and then to finisher on days 14 and 27, respectively. On days 3, 7, 14, 21, 27, 35, and 42, 
one bird per cage was euthanized via CO2 asphyxiation and luminal contents were aseptically 
collected from the mid-duodenum, mid-jejunum, mid-ileum, and cecum. Sample collection on 
days 14 and 27 was performed prior to feed transitions. Additionally, luminal contents were 
collected on day 42 from the crop, ventriculus, and colon of 12 broilers with one per cage for 
characterization of spatial differences in the chicken intestinal mycobiome.  
DNA isolation and sequencing 
Microbial DNA was isolated from intestinal contents using ZR Quick-DNA Fecal/Soil Microbe 
Microprep or Miniprep Kit (Zymo Research, Irvine, CA) according to the manufacturer’s 
protocol. DNA quality and quantity were determined using Nanodrop ND-1000 and the absence 
of degradation was confirmed using agarose gel electrophoresis. High-quality DNA was 
subjected to PE250 sequencing of the ITS2 region using ITS3 
(GCATCGATGAAGAACGCAGC) and ITS4 (TCCTCCGCTTATTGATATGC) primers on an 
Illumina HiSeq platform by Novogene (Novogene, Beijing, CA). PCR amplification and library 
preparation were performed using the NEBNext® Ultra™ DNA Library Prep Kit (New England 
Biolabs, Ipswich, MA).  
Absolute quantification of bacterial and fungal abundances 
Bacterial and fungal abundances in the GI tract were quantified by qPCR using the Femto 
Bacterial and Fungal DNA Quantification kits (Zymo Research), respectively.  
Bioinformatic analysis and statistics 
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Raw fungal sequences were imported into QIIME 2 and processed using the Deblur program (32, 
33). The ‘deblur denoise-other’ option was utilized, which included truncating sequences to 340 
nucleotides and positive-alignment based filtering against the UNITE reference database (34). 
Deblur uses error profiles within samples to achieve single-nucleotide resolution. Denoised 
sequences are often referred to as features, amplicon sequence variants (ASVs), or exact sequence 
variants (ESVs). Features appearing in less than 5% of samples were removed from downstream 
analysis. Data was normalized using cumulative sum scaling in the metagenomeSeq package of R 
(35). The remaining features were classified using the WARCUP v2 fungal ITS database and the 
Ribosomal Database Projects (RDP) Bayesian Classifier (36, 37). Bootstrap confidence was set to 
80% for every taxonomic level, and features with a classification of less than 80% were assigned 
the name of the last confidently assigned level followed by “_unidentified”. Species classification 
of the top 20 OTUs was confirmed through BLASTN search of the nucleotide database of 
GenBank. Analysis and visualization of the mycobiota composition was conducted in R version 
3.5.1 (38).  
The α-diversity was calculated using Shannon index, Observed Features (Observed 
OTUs), and Pielou’s Evenness index in the phyloseq package version 1.24.2 (39). Plots were 
made using ggplot2 version 3.0.0 (40). Results were plotted using box and whisker plots, in 
which the middle line denotes the median value and the lower and upper hinges represent the first 
and third quartiles, respectively. Whiskers extend from the hinge to the highest or lowest value no 
farther than 1.5× the inter-quartile range. Points outside of this range are considered outliers. The 
b-diversity was calculated using the Bray-Curtis and Jaccard indices in the phyloseq package of 
R. Dissimilarities were plotted as PCoA plots using phyloseq and ggplot2 in R.  
Prior to statistical analysis, normality of the data was determined using the Shapiro-Wilks 
test in R. Significant differences in α-diversity and relative abundance were determined using 
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Kruskal-Wallis and multiple comparisons were performed using pairwise Wilcoxon rank-sum 
test. Significant differences in b-diversity were determined using ANOSIM in mothur (41).  
RESULTS 
Biogeography of the chicken intestinal mycobiome 
To study the biogeography of the intestinal mycobiome in market-age broilers, intestinal contents 
were collected from seven different GI locations (crop, ventriculus, duodenum, jejunum, ileum, 
cecum, and colon) on day 42. Microbial DNA was isolated and sequenced on an Illumina HiSeq 
using the internal transcribed spacer 2 (ITS2) chemistry. A total of 26,364,044 quality-filtered 
sequences, with an average of 62,622 sequences per sample, were obtained and submitted to the 
deblur program. Following denoising and removal of rare features (present in less than 5% of 
samples), a total of 468 features were identified and included in downstream analysis.  
 Overall a-diversity was determined using the Shannon index (Fig. 1A), while richness 
and evenness were calculated using Observed Features (Fig. 1B) and Pielou’s Evenness (Fig. 1C), 
respectively. Shannon index revealed diversity to be lowest in the crop and increase in the 
ventriculus before reaching a maximum in the duodenum and jejunum. A decrease was observed 
in the lower GI tract with the cecum and colon returning to the levels similar to crop. This trend 
remained similar with richness (Fig 1.B) and evenness measurements (Fig 1.C) as well. 
Differences in fungal composition along the GI tract were measured with b-diversity analysis 
using the Bray-Curtis (Fig. 2A) and Jaccard (Fig. 2B) indices. Statistical analysis using ANOSIM 
revealed a significant difference in composition for both metrics (P = 0.001), with R values of 
0.745 and 0.685 for the Bray-Curtis and Jaccard indices, respectively. Both measurements 
indicated a separation of samples into three distinct clusters. The first was comprised entirely of 
the crop, ileum, colon samples, while the second consisted of the ventriculus, duodenum, and 
jejunum samples. In both metrics, the cecum was shown to cluster separately from all other GI 
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locations with the exception of one ventriculus sample located within the cluster. The presence of 
three clusters was further confirmed by pairwise comparisons using ANOSIM (Supplementary 
table 1). Large R values (> 0.800) were consistently seen when comparing GI locations in 
different clusters, regardless of the measurement used. For the Jaccard index, comparison of 
samples within the same cluster revealed moderate R values (0.334 – 0.765) indicating some 
difference in richness between GI locations. However, overall diversity between GI locations 
within the same cluster showed greater similarity with Bray-Curtis R values ranging from 0.009 
to 0.304.  
 Fungal composition revealed Ascomycota to be the most dominant phylum accounting 
for 97 to 99% of sequences in each GI location (Data not shown). A total of 65 genera were 
identified in the entire dataset with 56 of those present in the GI tract at 42 days of age. The most 
abundant genus at this time point was Gibberella accounting for 49.06% to 86.7% of all 
sequences, followed by Aspergillus (1.8% – 16.6%), and Candida (1.8 – 7.7%). Top 20 genera 
captured greater than 98% of the sequences in every intestinal location (Fig. 3A). While relative 
abundance varied throughout the intestinal tract, a specific bloom of Kabatiella, Davidiella, and 
Alternaria was observed in the duodenum and jejunum, which is in accordance with the increased 
a-diversity in those locations.  
 Investigation into fungal features revealed a significant difference in fungal taxa 
dominating each intestinal location (Fig 3. B). The top 20 fungal features accounted for more than 
75% of the sequences in each GI location except for the duodenum, where only 57% was 
captured. Consistent with b-diversity analysis, the most dominant features were shown to be 
similar between the crop, ileum, and cecum as well as between the ventriculus, duodenum, and 
jejunum. An unidentified Gibberella feature (F4) was dominant in the crop, ileum, and colon 
followed by Candida albicans F6 and Aspergillus flavus F8. Lower abundances of Trichosporon 
asahii F15 and Aspergillus amstelodami F20 were also present in these segments. A noticeable 
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shift was observed in the upper GI tract with the ventriculus, duodenum, and jejunum samples all 
dominated by one of two Fusarium pseudonygamai features (F1 and F2). However, similar to 
other GI locations, less abundant features were identified as C. albicans F7, T. asahii F17, and A. 
flavus F12, respectively. A difference in relative abundance of different features of the same 
species at different intestinal sites may indicate the presence of multiple sub-species within the GI 
tract.  
 The day-42 cecal mycobiome clustered separately from all other sample types in b-
diversity analyses. Consistently, they were shown to primarily consist of a unique Gibberella 
feature (F3) along with C. albicans (F5), A. flavus (F14), A. amstelodami (F16), and T. asahii 
(F21) (Fig. 3B). While these are all closely related to the Gibberella features observed in the 
crop, ileum, and colon, the difference in subtype residing in the cecum may be an indication of 
the fermentation process or transit time within the cecum. Statistical analysis with top 20 features 
revealed a significant difference among the GI location in all cases (Supplementary table 2), 
consistent with the fact that most features are only present in specific GI locations.  
Developmental changes of the chicken intestinal mycobiome 
To evaluate the development of the intestinal mycobiome throughout the growth cycle of broiler 
chickens, luminal contents were obtained from the duodenum, jejunum, ileum, and cecum on 
days 3, 7, 14, 21, 27, 35, and 42. Measurement of a-diversity using the Shannon index revealed a 
significant change in overall diversity in the jejunum, ileum, and cecum as birds aged (Fig. 4A). 
In the ileum and cecum, diversity appeared to be relatively consistent on days 3, 7, and 14 before 
increasing significantly on day 21. A steady decrease was then observed from day 27 to 42 (Fig. 
4A). This pattern was less clear in the jejunum, however, a sharp increase in diversity was noted 
on day 27 followed by a decrease on day 35. Diversity in the jejunum recovered slightly on day 
42. No significant difference in the Shannon index was observed for the duodenum.  
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 In the duodenum, richness of the fungal community, measured by Observed Features 
(Fig. 4B), remained relatively low from day 3 to day 21 before increasing significantly on days 27 
to 42. However, Pielou’s Evenness Index revealed a strong drop in evenness beginning on day 27 
and becoming even more pronounced on days 35 and 42 (Fig. 4C). In the jejunum, richness 
experienced a more gradual increase as birds aged (Fig. 4B), while evenness remained stable 
except for a significant increase on day 27 (Fig. 4C). While richness increased in the duodenum 
and jejunum with age, the number of observed features in the ileum decreased significantly from 
day 3 to day 7 and remained stable for the rest of the trial. Additionally, cecal richness varied 
only slightly throughout the entire growth cycle (Fig. 4B). Pielou’s Evenness index more closely 
resembled that of the Shannon index for both the ileum and cecum, indicating that diversity in 
these samples is driven by changes in species evenness rather than richness (Fig. 4C).  
 The b-diversity analysis revealed significant changes in fungal composition as birds aged. 
However, age dependent changes varied by GI location. In the duodenum, samples formed three 
primary clusters, in which the first was comprised solely of day 3 samples and the second of days 
7 and 14 as shown by Bray-Curtis analysis (Fig. 5A). The remaining samples were contained 
within the third cluster with diversity changing along a gradient from day 27 to 42. Ileum 
contents clustered similar to that of the duodenum with exception that days 21 to 42 were split 
into 2 distinct clusters containing days 21 and 27, and days 35 and 42, respectively (Fig. 5C). 
Jejunum samples clustered into four distinct groups with the first being comprised of day 3 and 
day 7, the second primarily of day 14, the third of day 27, and the fourth of samples from day 42 
(Fig. 5B). Samples from day 21 were dispersed between the day 14 and day 27 clusters while day 
35 was split between the day 21 and day 42 clusters. For the cecum, day 3 and 7, day 21, and 
days 35 and 42 formed three distinct clusters while day 14 and day 27 samples were dispersed 
between groups (Fig. 5D). Similar results were observed for the Jaccard index for every location 
(Supplementary figure 1). Pairwise ANOSIM further confirmed the presence of clusters at each 
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site with samples within the same cluster either not being statistically different from one another 
(P > 0.05) or having low R values indicating large overlap (R < 0.250). 
Ascomycota was the most dominant phyla in every segment regardless of age. However, 
a slight bloom of Basidiomycota was observed on days 14 to 27 (data not shown). At the genus 
level, Gibberella remained the most abundant, followed by Aspergillus and Candida, although 
relative abundance of each varied widely between locations and across ages (Fig. 6). 
Additionally, members of Trichosporon were shown to be moderately abundant in each GI 
segment with relative abundance ranging from 0.03 to 17.3% (data not shown). Investigation of 
bacterial features revealed obvious changes in fungal composition in each GI location as birds 
aged (Fig. 7). Four fungal features were predominant throughout the intestinal tract including two 
unidentified Gibberella (F3 and F4) and two F. pseudonygamai variants (F1 and F2). It is 
interesting to note that none of the four major features were observed to coexist in the same 
sample despite their similarity in sequence structure. This indicates that they are more likely to be 
different strains of the same species rather than the result of sequencing error. Consistently, less 
abundant features classified to the same species were absent.  
Transition and co-inhabitance of the chicken intestinal fungal consortia 
Compositional data also revealed a strong tendency for certain fungal features to co-inhabit in the 
GI tract. For example, C. albicans F7 was only found in conjunction with F. pseudonygamai F1, 
while C. albicans F9, F5, and F6 were solely associated with F. pseudonygamai F2, Gibberella 
sp. F3, and Gibberella sp. F4, respectively (Fig. 7). Statistical analysis of the top 20 genera in 
each GI location revealed a significant difference in almost every instance (Supplementary Table 
3). Similar to the biogeography data above, this is primarily driven by the presence of specific 
features at only a few time points in each GI location. 
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 The appearance order and timing of the intestinal mycobiome is especially noteworthy 
and was summarized in Fig. 8. No features were shown to persist in a single GI segment up to 
day 42, indicating a lack of a “core” mycobiome. Instead, the mycobiota is observed to be 
transient in nature with specific compositions moving down the GI tract in an orderly manner. 
Gibberella F3 was highly abundant in the duodenum on day 3, accounting for 46.4% of the 
population, but was not observed in this segment on any other sampling day. Rather, F3 began to 
appear in the jejunum on day 7 and became predominant on days 14 and 21. It then appeared in 
the ileum on days 21 and 27 before moving to the cecum on days 27 through 42. The same 
pattern of transition was observed for Gibberella F4 and F. pseudonygamai F2 (Fig. 8). 
Interestingly, F. pseudonygamai F1 was abundant in the cecum on days 3, 7, and 14, but did not 
appear in the duodenum on day 21. It then began to follow the pattern of succession seen above, 
moving to the jejunum on days 35 and 42. This is most likely an indication of a recycling of the 
microorganisms in the litter. As certain fungi are excreted into the environment, birds are 
reinoculated through ingestion of them from bedding materials, feed, and/or the cage.  
DISCUSSION 
Extensive work has been undertaken in the past ten years to characterize the intestinal 
microbiome of humans, mice, and livestock animals, as well as its relationship with health and 
disease (5, 6). However, very little is known about the intestinal mycobiota particularly in 
chickens. Fewer than 20 fungal species are typically reported using culture-based methods and 
Candida has been frequently described as the most abundant genus in the GI tract of chickens and 
turkeys, although dominant Candida species varies among different studies (27-30). Besides 
Candida, Trichosporon, Geotrichum, Rhodotorula, and Saccharomyces have been isolated in 
chickens as well (27-29). However, one other culture-dependent study reported the identification 
of 88 fungal species from over 3,000 cecal samples of broiler and layer chickens, with 
Aspergillus, Penicillium, Verticillium, and Sporidiobolus being the top four genera (31), whereas 
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a culture-independent 454 pyrosequencing method only reported two fungal species, 
Cladosporium sp. and Cladosporium sphaerospermum, in the cecum of broilers fed unmedicated 
diets (26), presumably due to a lack of the sequencing depth. 
A preliminary investigation into the chicken mycobiome by us used Illumina HiSeq deep 
sequencing of the ITS2 region revealed the presence of 659 unique fungal features with 
Scopulariopsis brevicaulis, Trichosporon asahii, and Aspergillus being predominant. In this 
study, we sought to follow up on our previous work by characterizing the biogeography of the 
chicken mycobiome on day 42, while comprehensively investigating successional changes in the 
intestinal mycobiome throughout the entire production cycle. Consistent with previous studies, 
we revealed Ascomycota and Basidiomycota to be abundant throughout the GI tract regardless of 
age or location. Gibberella was observed to be the most abundant genus followed by Candida and 
Aspergillus. Both Candida and Aspergillus are known to be abundant in humans, mice, and 
chickens (7, 15, 27, 29, 31, 42), while Gibberella has been identified as part of the oral 
mycobiome in humans (43).  Previously, although we identified Gibberella and Aspergillus to be 
among the most abundant genera, Microascus was the predominant member in broiler chickens 
on day 28, accounting for 40 – 62% of all sequences. While Microascus was identified in this 
study, its relative abundance was much lower, ranging from less than 0.01% to 4.4% (data not 
shown).  
While specific features varied throughout the intestinal tract, overall composition 
remained relatively stable. One of four Gibberella features was found to be most abundant 
regardless of bird age or GI location. Two were unable to be classified beyond the genus level (F4 
and F3), while two were identified as Fusarium pseudonygamai (F1 and F2). Along with each 
major feature, there was a specific set of minor species identified as C. albicans, A. flavus, A. 
amstelodami, S. fibuligera, and Trichosporon. Interestingly, the same set of specific features were 
found to co-exist in all cases forming four distinct mycobiome compositions. When four different 
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GI locations were sampled over the production cycle of a broiler, the intestinal mycobiome was 
found to be highly transient descending down the GI tract as birds age.  
While Candida is a known resident of the human mycobiome (7), the genera Gibberella, 
Aspergillus, and Trichosporon are commonly found in the soil or in association with plants and 
food material (44-47). Therefore, it is most likely that these features originate directly from the 
environment. This hypothesis is further strengthened by the observation that the fungal 
composition present in the lower GI tract (ileum and cecum) on days 3 and 7 reappeared in the 
duodenum on day 21. It is very likely that fungi present in the lower GI tract early in life were 
excreted into the litter and then re-introduced to the upper GI tract following their uptake from the 
environment. However, further study is needed to confirm the source of the intestinal mycobiota 
at hatch.  
In our previous study, fungal composition was shown to vary significantly along the GI 
tract with the upper GI tract (crop, ventriculus, and duodenum) hosting a more diverse mycobiota 
than the jejunum, ileum, and cecum. Similar results were seen with this study; however, an age 
dependent process was present in the form of decreased crop diversity and increased jejunum 
diversity on day 42 versus day 28. Moreover, a significant difference in both a- and b-diversity 
was observed in the duodenum, jejunum, ileum, and cecum over time, although the particulars of 
that change were site-specific. Our initial work also indicated an obvious switch in cecal 
composition between days 14 and 28, as noted by an increase S. brevicaulis features at the 
expense of T. asahii, which was speculated to indicate a maturation of the intestinal mycobiome. 
However, more thorough investigation into the dynamics of the mycobiome in this study has 
revealed that the switch was most likely an indication of the successional changes in cecal 
mycobiome composition as birds age. In humans, fecal mycobiota compositions have also been 
reported to be obviously different among healthy individuals of different age groups (48). 
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Specifically, an inverse relationship between the intestinal fungal α-diversity and age was 
observed, with infants and children harboring more fungal species than adults (48). 
In summary, we comprehensively studied the succession of the intestinal mycobiota 
throughout the production cycle of broiler chickens including the biogeography of the chicken 
intestinal mycobiome on day 42. Similar to previous studies, a-diversity was shown to be higher 
in the upper GI tract than the lower GI tract, while b-diversities varied significantly by age. 
Consistent with previous studies, the gut mycobiota was dominated by only a few fungal features. 
However, deep sequencing of samples from four adjacent GI locations over the entire production 
cycle revealed successional changes in fungal composition indicating the chicken gut mycobiome 
to be highly transient.  
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Table 4.S1. Pairwise ANOSIM of Biogeography Beta Diversity Indices 
 Crop Ventriculus Duodenum Jejunum Ileum Cecum Colon 
Crop 























































































































Table 4.S2. Biogeography of the chicken mycobiome at market age 
Feature Crop Vetriculus Duodenum Jejunum Ileum Cecum Colon P Value FDR 
F. pseudonygamai_F1 0.00a 71.24b 38.33c 67.21bc 0.00a 0.00a 0.00a <0.001 <0.001 
Gibberella sp. F4 84.89a 0.00c 0.00c 0.00c 75.43b 0.00c 81.37ab <0.001 <0.001 
Gibberella sp._F3 0.00a 4.42a 0.00a 0.00a 0.00a 85.82b 0.00a <0.001 <0.001 
F. pseudonygamai_F2 0.00ab 0.00ab 14.12a 0.00b 0.00b 0.00ab 0.00ab 0.001 0.001 
C. albicans_F5 0.00a 0.01a 0.00a 0.00a 0.00a 5.03b 0.00a <0.001 <0.001 
C. albicans_F6 5.80a 0.00c 0.00c 0.00c 6.35b 0.00c 6.66b <0.001 <0.001 
C. albicans_F7 0.00a 4.21b 1.27b 1.76b 0.00a 0.00a 0.00a <0.001 <0.001 
A. flavus_F8 1.51a 0.00c 0.00c 0.00c 7.85b 0.00c 4.25b <0.001 <0.001 
C. albicans_F9 0.00ab 0.00ab 0.83a 0.00b 0.00b 0.00ab 0.00ab 0.001 0.001 
Trichosporon sp._F15 0.07ac 0.00b 0.00b 0.00b 0.41c 0.00b 0.03a <0.001 <0.001 
Trichosporon sp._F17 0.00a 0.15b 0.72bd 0.02c 0.00a 0.00a 0.00a <0.001 <0.001 
S. fibuligera_F28 0.00a 0.00a 0.00a 0.00a 0.15b 0.00a 0.00a <0.001 <0.001 
A. flavus_F13 0.00ab 0.00ab 0.76a 0.00b 0.00b 0.00ab 0.00ab 0.001 0.001 
A. flavus_F12 0.00a 2.14b 1.24b 4.51c 0.00a 0.00a 0.00a <0.001 <0.001 
A. amstelodami_F16 0.00a 0.08a 0.00a 0.00a 0.00a 0.60b 0.00a <0.001 <0.001 
S. fibuligera_F32 0.00a 0.00a 0.07b 1.42c 0.00a 0.00a 0.00a <0.001 <0.001 
A. flavus_F14 0.00a 0.23a 0.00a 0.00a 0.00a 0.87b 0.00a <0.001 <0.001 
Hypocreales sp._F34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.201 0.201 
A. amstelodami_F20 0.51a 0.00c 0.00c 0.00c 0.71b 0.00c 0.62ab <0.001 <0.001 
Trichosporon sp _F21 0.00a 0.00a 0.00a 0.00a 0.00a 0.23b 0.00a <0.001 <0.001 
 
Note: Mean relative abundance (%) of the phylum, top 20 fungal features are shown, with 10 to 12 samples 
per intestinal segment. Statistical significance was determined using non-parametric Kruskal Wallis test 
and p values were corrected for multiple comparisons using the Benjamini-Hochberg correction. For 
columns with an FDR ≤  0.05, means were separated using pairwise Wilcoxon Rank Sums test. Columns 
not sharing a common superscript are considered significantly different (P < 0.05).  Note: Among the top 
20 features, only three unclassified Trichosporon species belonged to the phylum Basidiomycota. The rest 
belonged to Ascomycota. 
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Duodenum     
D14-D21 1.000 <0.001 1.000 <0.001 
D14-D27 1.000 <0.001 1.000 <0.001 
D14-D3 0.431 0.001 0.369 0.006 
D14-D35 1.000 <0.001 1.000 <0.001 
D14-D42 0.750 <0.001 0.750 <0.001 
D14-D7 0.064 0.147 0.137 0.031 
D21-D27 0.221 0.007 0.874 <0.001 
D21-D3 0.767 <0.001 0.767 <0.001 
D21-D35 0.307 <0.001 0.947 <0.001 
D21-D42 0.269 0.002 0.591 <0.001 
D21-D7 1.000 <0.001 1.000 <0.001 
D27-D3 0.741 <0.001 0.741 <0.001 
D27-D35 0.111 0.036 0.071 0.101 
D27-D42 0.106 0.057 0.163 0.009 
D27-D7 1.000 <0.001 1.000 <0.001 
D3-D35 0.767 <0.001 0.767 <0.001 
D3-D42 0.519 <0.001 0.519 <0.001 
D3-D7 0.575 <0.001 0.438 0.002 
D35-D42 0.083 0.078 0.012 0.315 
D35-D7 1.000 <0.001 1.000 <0.001 
D42-D7 0.824 <0.001 0.824 <0.001 
Jejunum     
D14-D21 0.109 0.054 0.306 <0.001 
D14-D27 1.000 <0.001 1.000 <0.001 
D14-D3 1.000 <0.001 1.000 <0.001 
D14-D35 0.795 <0.001 0.795 <0.001 
D14-D42 1.000 <0.001 1.000 <0.001 
D14-D7 0.387 <0.001 0.417 0.001 
D21-D27 0.464 <0.001 0.314 0.002 
D21-D3 0.758 <0.001 0.758 <0.001 
D21-D35 0.275 0.002 0.260 0.003 
D21-D42 0.758 <0.001 0.758 <0.001 
D21-D7 0.306 0.002 0.313 <0.001 
D27-D3 1.000 <0.001 1.000 <0.001 
D27-D35 0.252 0.001 0.140 0.008 
D27-D42 1.000 <0.001 1.000 <0.001 
D27-D7 0.736 <0.001 0.736 <0.001 
D3-D35 0.795 <0.001 0.795 <0.001 
D3-D42 1.000 <0.001 1.000 <0.001 
D3-D7 0.069 0.102 0.107 0.034 
D35-D42 0.571 <0.001 0.720 <0.001 
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D35-D7 0.553 <0.001 0.553 <0.001 
D42-D7 0.758 <0.001 0.758 <0.001 
Ileum     
D14-D21 1.000 <0.001 1.000 <0.001 
D14-D27 1.000 <0.001 1,000 <0.001 
D14-D3 1.000 <0.001 1.000 <0.001 
D14-D35 1.000 <0.001 1.000 <0.001 
D14-D42 1.000 <0.001 1.000 <0.001 
D14-D7 0.024 0.666 0.085 0.054 
D21-D27 0.057 0.142 0.131 0.003 
D21-D3 1.000 <0.001 1.000 <0.001 
D21-D35 1.000 <0.001 1.000 <0.001 
D21-D42 1.000 <0.001 1.000 <0.001 
D21-D7 1.000 <0.001 1.000 <0.001 
D27-D3 1.000 <0.001 1.000 <0.001 
D27-D35 1.000 <0.001 1.000 <0.001 
D27-D42 1.000 <0.001 1.000 <0.001 
D27-D7 1.000 <0.001 1.000 <0.001 
D3-D35 1.000 <0.001 1.000 <0.001 
D3-D42 1.000 <0.001 1.000 <0.001 
D3-D7 1.000 <0.001 1.000 <0.001 
D35-D42 0.013 0.546 0.069 0.92 
D35-D7 1.000 <0.001 1.000 <0.001 
D42-D7 1.000 <0.001 1.000 <0.001 
Cecum     
D14-D21 0.074 0.112 0.077 0.090 
D14-D27 0.082 0.096 0.077 0.075 
D14-D3 0.315 0.001 0.382 0.001 
D14-D35 0.685 <0.001 0.685 <0.001 
D14-D42 0.711 <0.001 0.711 <0.001 
D14-D7 0.321 0.002 0.400 0.001 
D21-D27 0.022 0.291 0.122 0.020 
D21-D3 1.000 <0.001 1.000 <0.001 
D21-D35 1.000 <0.001 1.000 <0.001 
D21-D42 1.000 <0.001 1.000 <0.001 
D21-D7 1.000 <0.001 1.000 <0.001 
D27-D3 0.812 <0.001 0.811 <0.001 
D27-D35 0.465 0.001 0.582 <0.001 
D27-D42 0.475 <0.001 0.551 <0.001 
D27-D7 0.790 <0.001 0.790 <0.001 
D3-D35 1.000 <0.001 1.000 <0.001 
D3-D42 1.000 <0.001 1.000 <0.001 
D3-D7 0.021 0.575 0.047 0.104 
D35-D42 0.102 0.059 0.110 0.039 
D35-D7 1.000 <0.001 1.000 <0.001 
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Table 4.S4. Temporal shifts in fungal feature composition 
 D3 D7 D14 D21 D27 D35 D42 P Value FDR 
Duodenum          
F. pseudonygamai_F1 0.00a 0.00a 0.00b 26.81c 38.10cd 56.04d 38.33cd < 0.001 < 0.001 
Gibberella sp._F3 46.44a 0.00b 0.00b 0.00b 0.00b 0.00b 0.00b < 0.001 < 0.001 
F. pseudonygamai_F2 0.00ab 0.00a 0.00ab 0.00ab 0.00ab 0.00ab 14.12b 0.002 0.002 
Gibberella sp._F4 9.83a 46.87b 35.72b 0.00a 0.00a 0.00a 0.00a < 0.001 < 0.001 
C. albicans_F5 0.34a 0.00b 0.00b 0.00b 0.00b 0.00b 0.00b < 0.001 < 0.001 
C. albicans_F6 0.42ac 1.86b 4.51bc 0.00a 0.00a 0.00a 0.00a < 0.001 < 0.001 
C. albicans_F7 0.00a 0.00a 0.00a 13.21b 8.07b 13.63b 1.27c < 0.001 < 0.001 
A. flavus_F8 0.19a 3.65b 1.91c 0.00a 0.00a 0.00a 0.00a < 0.001 < 0.001 
C. albicans_F9 0.00ab 0.00a 0.00ab 0.00ab 0.00ab 0.00ab 0.83b 0.002 0.002 
Trichosporon sp _F15 0.39a 2.20b 10.10b 0.00a 0.00a 0.00a 0.00a < 0.001 < 0.001 
Trichosporon sp _F17 0.00a 0.00a 0.00a 11.43bc 12.39c 0.58b 0.72b < 0.001 < 0.001 
S. fibuligera_F28 3.24a 10.18b 9.55b 0.00a 0.00a 0.00a 0.00a < 0.001 < 0.001 
A. flavus_F13 0.00ab 0.00b 0.00ab 0.00ab 0.00ab 0.00ab 0.76a 0.002 0.002 
A. amstelodami_F16 0.20a 0.00b 0.00b 0.00b 0.00b 0.00b 0.00b < 0.001 < 0.001 
S. fibuligera_F32 0.00a 0.00a 0.00a 16.78b 2.63c 0.01c 0.07c < 0.001 < 0.001 
A. flavus_F12 0.00a 0.00a 0.00a 0.65b 1.29bc 3.20c 1.24bc < 0.001 < 0.001 
Hypocreales sp. _F34 1.83a 9.45a 8.26a 0.00b 0.00b 0.00b 0.00b < 0.001 < 0.001 
A. flavus_F14 0.55a 0.00b 0.00b 0.00b 0.00b 0.00b 0.00b < 0.001 < 0.001 
Trichosporon sp _F21 0.19a 0.00b 0.00b 0.00b 0.00b 0.00b 0.00b < 0.001 < 0.001 
A. amstelodami_F20 0.18a 5.78a 2.15a 0.00b 0.00b 0.00b 0.00b < 0.001 < 0.001 
Jejunum          
F. pseudonygamai_F1 0.00a 0.00a 0.00a 0.00a 0.00a 18.91a 67.21b < 0.001 < 0.001 
Gibberella sp. _F3 0.00a 26.17b 69.12b 45.93b 0.00a 0.00a 0.00a < 0.001 < 0.001 
F. pseudonygamai_F2 73.61a 53.53a 0.00b 0.00b 0.00b 0.00b 0.00b < 0.001 < 0.001 
Gibberella sp. _F4 0.00a 0.00a 0.00a 23.51b 55.10bc 55.58c 0.00a < 0.001 < 0.001 
C. albicans_F5 0.00a 2.00b 9.89c 9.25c 0.00a 0.00a 0.00a < 0.001 < 0.001 
C. albicans_F6 0.00a 0.00a 0.00a 4.63b 11.87c 8.55bc 0.00a < 0.001 < 0.001 
C. albicans_F7 0.00a 0.00a 0.00a 0.00a 0.00a 2.83a 1.76b < 0.001 < 0.001 
A. flavus_F8 0.00a 0.00a 0.00a 0.49b 2.95c 3.33c 0.00a < 0.001 < 0.001 
C. albicans_F9 1.32a 0.04b 0.00c 0.00c 0.00c 0.00c 0.00c < 0.001 < 0.001 
Trichosporon sp _F15 0.00a 0.00a 0.00a 0.70ac 9.29b 0.85bc 0.00a < 0.001 < 0.001 
Trichosporon sp _F17 0.00a 0.00a 0.00a 0.00a 0.00a 0.00a 0.02b < 0.001 < 0.001 
S. fibuligera_F28 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NA NA 
A. flavus_F13 4.65a 3.59a 0.00b 0.00b 0.00b 0.00b 0.00b < 0.001 < 0.001 
A. amstelodami_F16 0.00a 0.36b 2.39c 2.70bc 0.00a 0.00a 0.00a < 0.001 < 0.001 
S.  fibuligera_F32 0.00a 0.00a 0.00a 0.00a 0.00a 0.00a 1.42b < 0.001 < 0.001 
A. flavus_F12 0.00a 0.00a 0.00a 0.00a 0.00a 1.13a 4.51b < 0.001 < 0.001 
Hypocreales sp. _F34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.433 0.433 
A. flavus_F14 0.00a 1.64b 3.63c 0.92b 0.00a 0.00a 0.00a < 0.001 < 0.001 
Trichosporon sp _F21 0.00a 0.14b 2.22c 2.48bc 0.00a 0.00a 0.00a < 0.001 < 0.001 
A. amstelodami_F20 0.00a 0.00a 0.00a 0.75b 3.53c 0.55b 0.00a < 0.001 < 0.001 
Ileum          
F. pseudonygamai_F1 78.91a 0.00a 0.00a 0.00a 0.00a 0.00a 0.00a < 0.001 < 0.001 
Gibberella sp_F3 0.00a 0.00a 0.00a 56.25b 66.75b 0.00a 0.00a < 0.001 < 0.001 
F. pseudonygamai_F2 0.00a 75.39b 77.27b 0.00a 0.00a 0.00a 0.00a < 0.001 < 0.001 
Gibberella sp. _F4 0.00a 0.00a 0.00a 0.00a 0.00a 67.75b 75.43b < 0.001 < 0.001 
C. albicans_F5 0.00a 0.00a 0.00a 17.12b 11.45b 0.00a 0.00a < 0.001 < 0.001 
C. albicans_F6 0.00a 0.00a 0.00a 0.00a 0.00a 10.90b 6.35b < 0.001 < 0.001 
C. albicans_F7 1.09a 0.00b 0.00b 0.00b 0.00b 0.00b 0.00b < 0.001 < 0.001 
A. flavus_F8 0.00a 0.00a 0.00a 0.00a 0.00a 8.44b 7.85b < 0.001 < 0.001 
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C. albicans_F9 0.00a 1.19b 4.65b 0.00a 0.00a 0.00a 0.00a < 0.001 < 0.001 
Trichosporon sp _F15 0.00a 0.00a 0.00a 0.00a 0.00a 0.24b 0.41b < 0.001 < 0.001 
Trichosporon sp _F17 0.11a 0.00b 0.00b 0.00b 0.00b 0.00b 0.00b < 0.001 < 0.001 
S. fibuligera_F28 0.00a 0.00a 0.00a 0.00a 0.00a 0.03b 0.15c < 0.001 < 0.001 
A. flavus_F13 0.00a 4.03b 5.37b 0.00a 0.00a 0.00a 0.00a < 0.001 < 0.001 
A. amstelodami_F16 0.00a 0.00a 0.00a 9.38b 2.24c 0.00a 0.00a < 0.001 < 0.001 
S. fibuligera_F32 0.08a 0.00b 0.00b 0.00b 0.00b 0.00b 0.00b < 0.001 < 0.001 
A. flavus_F12 6.03a 0.00b 0.00b 0.00b 0.00b 0.00b 0.00b < 0.001 < 0.001 
Hypocreales sp. _F34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.423 0.423 
A. flavus_F14 0.00a 0.00a 0.00a 3.53b 5.47b 0.00a 0.00a < 0.001 < 0.001 
Trichosporon sp _F21 0.00a 0.00a 0.00a 3.53b 4.47b 0.00a 0.00a < 0.001 < 0.001 
A. amstelodami_F20 0.00a 0.00a 0.00a 0.00a 0.00a 1.49b 0.71c < 0.001 < 0.001 
Cecum          
F. pseudonygamai_F1 91.62a 90.65a 35.59b 0.00c 0.00c 0.00c 0.00c < 0.001 < 0.001 
Gibberella sp. _F3 0.00a 0.00a 0.00a 0.00a 24.87a 85.00b 85.82b < 0.001 < 0.001 
F. pseudonygamai_F2 0.00a 0.00a 45.40b 66.83b 55.21b 0.00a 0.00a < 0.001 < 0.001 
Gibberella sp. _F4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NA NA 
C. albicans_F5 0.00a 0.00a 0.00a 0.00a 2.14a 7.44b 5.03b < 0.001 < 0.001 
C. albicans_F6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NA NA 
C. albicans_F7 0.14a 0.83b 0.72a 0.00b 0.00b 0.00b 0.00b < 0.001 < 0.001 
A. flavus_F8 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NA NA 
C. albicans_F9 0.00a 0.00a 1.77b 9.22c 6.69bc 0.00a 0.00a < 0.001 < 0.001 
Trichosporon sp _F15 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NA NA 
Trichosporon sp _F17 0.14ab 0.13a 0.03bc 0.00cd 0.00cd 0.00cd 0.00d < 0.001 < 0.001 
S. fibuligera_F28 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NA NA 
A. flavus_F13 0.00a 0.00a 0.32b 0.56b 0.35b 0.00a 0.00a < 0.001 < 0.001 
A. amstelodami_F16 0.00a 0.00a 0.00a 0.00a 0.06b 0.44b 0.60b < 0.001 < 0.001 
S. fibuligera_F32 0.00a 0.00ab 0.00b 0.00ab 0.00ab 0.00ab 0.00ab 0.007 0.007 
A. flavus_F12 0.19a 0.16a 0.08b 0.00c 0.00c 0.00c 0.00c < 0.001 < 0.001 
Hypocreales sp. _F34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NA NA 
A. flavus_F14 0.00a 0.00a 0.00a 0.00a 0.04a 0.70b 0.87b < 0.001 < 0.001 
Trichosporon sp_F21 0.00a 0.00a 0.00a 0.00a 1.39ab 0.19b 0.23b < 0.001 < 0.001 
A. amstelodami_F20 0.00 0.00 0.00 0.00 0.00 0.00 0.00 NA NA 
Note: Mean relative abundance (%) of the phylum, top 20 fungal features are shown, with 10 to 12 samples 
per intestinal segment. Statistical significance was determined using non-parametric Kruskal Wallis test 
and p values were corrected for multiple comparisons using the Benjamini-Hochberg correction. For 
columns with an FDR ≤  0.05, means were separated using pairwise Wilcoxon Rank Sums test. Columns 






Fig. 4.1. Variation in the α-diversity of the mycobiome along the gastrointestinal tract of 
day-42 chickens. Overall diversity, richness, and evenness were calculated from 10-12 luminal 
content samples of each intestinal segment using the Shannon Index (A), Observed Features (B), 
and Pielou’s Evenness index, respectively. Significant differences were determined using the 
Kruskal-Wallis test and means were separated with pairwise Wilcoxon rank-sum tests with the 







Fig. 4.2. Principal coordinate analysis (PCoA) of the mycobiome along the gastrointestinal 
tract of day-42 chickens. Luminal content samples were collected from each gastrointestinal 
segment of 10-12 chickens. PCoA was plotted using Bray-Curtis (A) and the Jaccard indices (B), 





Fig. 4.3. Biogeographical variation in mycobiota composition of the gastrointestinal tract of 
day-42 chickens. Luminal content samples were collected from each gastrointestinal segment. 
Relative abundance of features was used to determine the fungal composition at the genus (A) 








Fig. 4.4. Successional changes in the α-diversity chicken mycobiota. Luminal content samples 
were collected from the duodenum, jejunum, ileum, and cecum of chicks fed an antibiotic-free 
diet on days 3, 7, 14, 21, 27, 35, and 42. The a-diversity was calculated from 10 to 12 samples on 
each sampling day and indicated by the Shannon Index (A), Observed Features (B), and Pielou’s 
Evenness, respectively. Significant differences were determined using the Kruskal-Wallis test and 
means were separated with pairwise Wilcoxon rank-sum tests with the segments not sharing a 




Fig. 4.5. Variation in β-diversity of the chicken intestinal mycobiota. Luminal content 
samples were collected from the duodenum, jejunum, ileum, and cecum of chicks fed an 
antibiotic-free diet on days 3, 7, 14, 21, 27, 35, and 42, respectively. Principal coordinate analysis 
(PCoA) was plotted from 10 to 12 samples on each sampling day using Bray-Curtis index. 





Fig. 4.6. Developmental changes in the intestinal mycobiota composition of chickens. 
Luminal content samples were collected from four gastrointestinal segments of broiler chickens 
on seven different sampling days. Relative abundance was calculated at the genus level with 10 to 




Fig. 4.7. Shift in the intestinal mycobiota composition over a production cycle of chickens. 
Luminal content samples were collected from four gastrointestinal segments on seven different 
sampling days. Relative abundance of each feature was calculated with 10 to 12 samples per 




Fig. 4.8. Age-dependent transition of four specific fungal consortia along the intestinal tract. 
Passage of four distinct fungal consortia down the intestinal tract is summarized. Full circles 
indicate that only one consortium was observed for that location on that day. Half circles 






DIFFERENTIAL IMPACT OF SUBTHERAPEUTIC ANTIBIOTICS AND IONOPHORES ON 
CECAL MICROBIOTA OF BROILERS 
 
Kelsy Robinson 1, Sage Becker 1, Yingping Xiao 2, Wentao Lyu 2, Qing Yang 1, Huiling Zhu 3, 
Hua Yang 2, Jiangchao Zhao 4, and Guolong Zhang 1,* 
1 Department of Animal and Food Sciences, Oklahoma State University, Stillwater, Oklahoma 
74078, U.S.A. 
2 Institute of Quality and Standards for Agro-products, Zhejiang Academy of Agricultural 
Sciences, Hangzhou 310021, China 
3 Hubei Key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, 
Hubei 430000, China 
4 Department of Animal Science, Division of Agriculture, University of Arkansas, Fayetteville, 
Arkansas 72701, U.S.A. 
* Correspondence: zguolon@okstate.edu; Tel.: +01-405-744-8867 
† This chapter was published in Microorganisms 2019, 7 (9): E282. DOI: 





Antimicrobial growth promoters (AGPs) are commonly used in the livestock industry at 
subtherapeutic levels to improve production efficiency, which is achieved mainly through 
modulation of the intestinal microbiota. However, how different classes of AGPs, particularly 
ionophores, regulate the gut microbiota remains unclear. In this study, male Cobb broiler 
chickens were supplemented for 14 days with or without one of five commonly used AGPs 
including three classical antibiotics (bacitracin methylene disalicylate, tylosin, and virginiamycin) 
and two ionophores (monensin and salinomycin) that differ in antimicrobial spectrum and 
mechanisms. Deep sequencing of the V3-V4 region of the bacterial 16S rRNA gene revealed that 
two ionophores drastically reduced a number of rare bacteria resulting in a significant decrease in 
richness and a concomitant increase in evenness of the cecal microbiota, whereas three antibiotics 
had no obvious impact. Although each AGP modulated the gut microbiota differently, the closer 
the antibacterial spectrum of AGPs, the more similarly the microbiota is regulated. Importantly, 
all AGPs had a strong tendency to enrich butyrate- and lactic acid-producing bacteria, while 
reducing bile salt hydrolase-producing bacteria, suggesting enhanced metabolism and utilization 
of dietary carbohydrates and lipids and improved energy harvest, which is at least partially 
responsible for the growth-promoting effect of AGPs. 
 








Subtherapeutic antimicrobial growth promoters (AGPs) are commonly included in livestock diets 
to improve production performance [1,2]. This is particularly true in the poultry industry where 
supplementation has been shown to improve weight gain and feed efficiency, inhibit pathogen 
growth, and reduce mortality [2,3]. However, increased microbial resistance linked to antibiotic 
use in food animals has led to a ban on AGPs and a change in consumer preference towards 
products from animals raised without antibiotics [1,4,5]. This has, therefore, created a need to 
develop antibiotic alternatives to ensure animal health and growth performance. 
While the exact mode of action remains elusive, AGPs are postulated to provide 
performance benefits through modulation of the intestinal microbiota [2,6,7,8]. Indeed, the 
inability of antibiotics to improve growth performance in germ-free chicks has provided 
compelling evidence that antibiotics work primarily by reshaping the intestinal microbiota [9], 
which is a unique ecosystem known to play a vital role in host health and metabolism through its 
effects on feed digestion, nutrient absorption, vitamin synthesis, and immune system development 
[10,11,12]. Consistently, a link between the intestinal microbiota and growth performance of 
livestock animals has been established [7,13,14]. For example, two specific fecal bacterial 
community structures known as enterotypes are significantly associated with body weight and 
average daily gain of pigs [15]. Similar studies in broiler chickens have revealed a strong 
correlation between certain intestinal bacterial taxa and weight gain [16]. Specific AGP-induced 
changes in the intestinal microbiota are beginning to be elucidated [2,7,8]. However, the wide 
range of AGPs used between studies, as well as differences in animal age, diet, genetics, 
management condition, DNA isolation, and sequencing strategies, make it difficult to draw a 
definitive conclusion from the current literature. It remains unknown whether different classes of 
AGPs such as classical antibiotics and ionophores modulate the intestinal microbiota in similar or 
distinct manners.  
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In this study, we directly compared the effects of five AGPs including bacitracin 
methylene disalicylate (BMD), tylosin, virginiamycin, monensin, and salinomycin on the cecal 
microbiota of broilers. These five AGPs were chosen because they are commonly used in the 
poultry industry and are known to have different antimicrobial spectra and mechanisms. BMD is 
a broad-spectrum cyclic peptide antibiotic that functions through inhibition of bacterial cell wall 
synthesis, while tylosin, a macrolide, and virginiamycin, a streptogramin, both target Gram-
positive bacteria by inhibiting bacterial protein synthesis [2,17]. Monensin and salinomycin, on 
the other hand, are polyether ionophores that act against coccidia and Gram-positive bacteria by 
transporting ions and dissipating ion gradients across bacterial cell membranes [2,17]. Based on 
deep sequencing of the V3-V4 region of the bacterial 16S rRNA gene after 2-week subtherapeutic 
supplementation of five AGPs, we revealed in the current study an obvious shift in the structure 
of the cecal bacterial community, with two ionophores having the most striking effect. 
Identification of a number of bacterial taxa that are commonly and uniquely altered in response to 
different AGPs shed new light on their growth-promoting mechanism and may allow targeted 
manipulation of the cecal microbiota to improve animal health and productivity in the future.  
Materials and Methods  
Animal trial 
All animal trials were conducted in accordance with the Institutional Animal Care and Use 
Committee of Oklahoma State University. A total of 576 day-of-hatch male Cobb broiler chicks 
were obtained from the Cobb-Vantress Hatchery (Siloam Springs, AR) and randomly assigned to 
one of six dietary treatments with eight birds per cage and 12 cages per treatment. Animals 
received either a non-medicated standard corn-soybean starter diet, formulated to meet or exceed 
NRC requirements, or the starter diet supplemented with one of five AGPs for 14 days. The 
supplemental levels were BMD (0.5 g BMD®-50/kg diet, equivalent to 55 mg BMD/kg, Zoetis, 
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Parsippany, NJ), tylosin (0.5 g Tylan®-40/kg, equivalent to 44 mg tylosin/kg, Elanco Animal 
Health, Greenfield, IN), virginiamycin (0.5 g Stafac®-20/kg, equivalent to 22 mg 
virginiamycin/kg, Phibro Animal Health, Teaneck, NJ), monensin (0.5 g Coban®-90/kg, 
equivalent to 99 mg monensin/kg, Elanco Animal Health), and salinomycin (0.5 g Bio-Cox®-
60/kg, equivalent to 66 mg salinomycin/kg, Zoetis), respectively. All antimicrobial doses are 
recommended at subtherapeutic levels for disease prevention and growth promotion by respective 
manufacturers. The chickens were raised on floor cages with fresh pine wood shavings under 
standard management. Water and feed were provided ab libitum for the entire duration of the 
trial. The room temperature was started at 33˚C and decreased 3˚C every 7 days. The light to dark 
ratio was 24:0 for day 0, 23:1 for days 1 to 3, 18:6 for days 4 to 6, and 16:8 for days 7 to 14. 
Modification of room temperature and lighting was designed in accordance with industry 
standards to ensure optimal bird growth. On day 14, two chicks were randomly selected from 
each cage and euthanized via CO2 asphyxiation. Cecal content was collected from each bird for 
microbiome analysis. The samples were immediately frozen in liquid nitrogen and stored at -80˚C 
until further processing. 
DNA extraction and sequencing 
Bacterial DNA was isolated from cecal contents using the ZR Fecal DNA Isolation Kit (Zymo 
Research, Irvine, CA) according to the manufacturer’s protocol. The quality and quantity of DNA 
samples were determined using a Nanodrop ND-1000, and agarose gel electrophoresis was used 
to confirm the absence of degradation. High quality DNA was sequenced for the V3-V4 region of 
the 16S rRNA gene by Novogene (Beijing, CA) on Illumina HiSeq2000 using 341F 
(CTAYGGGRBGCASCAG) and 806R (GGACTACNNGGGTATCTAAT) primers. Novogene’s 
standard protocol using the NEB Next® Ultra™ Library Prep Kit was used for PCR amplification 
and library preparation. 
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Bioinformatic analysis and statistics 
Raw sequences were processed using mothur, version 1.39.5 [18], according to the standard 
operating procedures. Low quality sequences and singletons were removed. Sequences were 
aligned using the SILVA database prior to classification using the RDP 16S rRNA training set 16. 
Sequences that shared no less than 97% identity were clustered into one operational taxonomic 
unit (OTU) and relative abundance was calculated. Differences in the microbial community 
structure were calculated using R version 3.5.1 [19]. The α- and β-diversities were calculated with 
the phyloseq package, version 1.24.2 [20], while plots were made using ggplot2 version 3.0.0 
[21]. Statistical differences in α-diversity and relative abundance were determined using one-way 
ANOVA with post hoc Tukey’s test in R. The α-diversity was calculated using the Shannon 
Evenness index and Observed OTUs as measures of evenness and richness, respectively. Results 
were plotted using box and whisker plots, in which the middle line denotes the median value and 
the lower and upper hinges represent the first and third quartiles, respectively. Whiskers extend 
from the hinge to the highest or lowest value no farther than 1.5× the inter-quartile range. Points 
outside of this range are considered outliers. 
The β-diversity was calculated using Bray-Curtis and Jaccard indices and statistical 
difference in the microbiome composition was determined using analysis of similarity 
(ANOSIM) in the vegan package of R, version 2.5.2 [22]. Metastats [23] was used to determine 
significant differences in the relative abundance of each OTU between individual treatments and 
the control group. Venn diagrams were drawn using the VennDiagram package of R [24], and 
heatmap was generated using Heatmapper [25].  
Accession number 
Sequencing data for this experiment was deposited into NCBI SRA and can be found under the 




Effect of in-feed antimicrobials on the cecal bacterial diversity  
Male Cobb broiler chicks were fed a non-medicated corn-soybean basal diet supplemented with 
or without one of five commonly used AGPs at subtherapeutic levels for two weeks before 
collection of 12 cecal content samples for each treatment. Following bacterial DNA isolation and 
sequencing of the V3-V4 region of the 16S rRNA gene, a total of 7,767,847 raw sequence reads 
were obtained with an average of 107,866 ± 11,583 sequences per sample. After quality trimming 
and processing, 6,522,487 reads remained and were further clustered into 2,416 OTUs. Sequences 
were subsampled to a depth of 56,629 sequences per sample for subsequent analysis.  
The α-diversity was first calculated using Shannon Evenness Index (Figure 1A) and 
Observed OTUs (Figure 1B). Both measurements revealed a trend toward a decrease in both 
evenness and richness of the cecal microbiota in response to three antibiotics (BMD, tylosin, and 
virginiamycin). Surprisingly, two ionophores (monensin and salinomycin) led to a significant 
increase (P < 0.05) in evenness of the microbiota, which was accompanied by a drastic decrease 
in richness (P < 0.05). To further reveal the difference in the cecal microbiota α-diversity between 
antibiotics and ionophores, data from three antibiotics and two ionophore groups were combined 
separately and α-diversity was calculated. Similar to individual treatments, ionophores caused a 
significant increase in evenness (P < 0.05) (Figure 1C) and a concomitant decrease in richness (P 
< 0.05) (Figure 1D), whereas the effect of antibiotics on cecal bacterial α-diversity was 
insignificant, suggesting that ionophores have a more pronounced effect than antibiotics on 
reshaping the cecal microbiota.  
To further reveal the differences in cecal microbiota composition among individual 
AGPs, β-diversity was determined using the Bray-Curtis and Jaccard indices. While there was no 
obvious segregation of the microbiota based on the Bray-Curtis Index (Figure 2A), two ionophore 
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groups were clearly separated from all other treatments using the Jaccard Index (Figure 2B), 
reinforcing an earlier observation on α-diversity that in-feed ionophores had a stronger effect on 
cecal microbiota than antibiotics. Consistently, ANOSIM indicated that the differences in the 
Bray-Curtis index among treatments are mostly significant (P < 0.05), but generally minor (with a 
low R value ranging from 0.048 to 0.411) (Table 1). However, for the Jaccard index, all three 
antibiotics and the control group had very low R values of less than 0.1 among each other, 
whereas the highest R values were observed when comparing the two ionophore groups to any 
other group (R > 0.7 for all comparisons) (Table 1), in agreement with the α-diversity analysis in 
that two inophores significantly reduced richness of the cecal microbiota, while three antibiotics 
had relatively a mild effect (Fig. 1D). 
Effect of in-feed antimicrobials on cecal bacterial composition 
At the phylum level, Firmicutes was found to be the most abundant phylum accounting for over 
97% of all sequences, followed by Proteobacteria and Bacteroidetes in the cecum of day-14 
broilers (Figure 3A). Statistical analysis revealed no significant difference in relative abundance 
of Firmicutes or Proteobacteria among treatments (Supplementary Table 1). Relative abundance 
of Bacteroidetes and Actinobacteria varied significantly among the treatments (P < 0.05). 
Virginiamycin resulted in a significant decrease in Actinobacteria, relative to the control group, 
while BMD significantly increased Bacteroidetes as compared to tylosin and monensin (P < 0.05) 
(Supplementary Table 1). At the genus level, over 48% of sequences were identified as 
unclassifiable members of Lachnospiraceae (Figure 3A). Statistical analysis of the top 10 genera 
revealed differential effects of AGP supplementation on members of Ruminococcaceae, 
Clostridiales, and Romboutsia. For example, tylosin supplementation caused a significant 
increase in an unclassified genus of the Ruminococcaceae family relative to the control group (P 
< 0.05), while virginiamycin resulted in a significant diminishment of Romboutsia of the 
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Peptostreptococcaceae family and a concomitant increase in an unclassified genus of the 
Clostridia class as compared to control (P < 0.05) (Supplementary Table 1).  
When three antibiotics and two ionophore groups were combined and compared with the 
control group, no significant difference in relative abundance of Firmicutes, Proteobacteria, or 
Bacteroidetes was observed at the phylum level, while Actinobacteria was significantly reduced 
by antibiotics, but not ionophores (Figure 3B and Supplementary Table 2). At the genus level, a 
significant increase in unclassified Ruminococcaceae was observed in the antibiotics group over 
control (P < 0.05), while ionophores had a minimum impact (Figure 3B and Supplementary Table 
2). Romboutsia was significantly augmented in response to antibiotics (P < 0.05), but remained 
unaltered by ionophores (Supplementary Table 2). When all five AGP groups were pooled and 
compared to the control (Figure 3C), Firmicutes was slightly, but significantly decreased by 
AGPs, while the opposite was true with Proteobacteria (Supplementary Table 3). A significant 
increase in an unclassified member of both Ruminococcaceae and Clostridiales was observed (P 
< 0.05), while all other genera remained largely unchanged (Supplementary Table 3). 
Differential regulation of OTUs by antimicrobial supplementation 
In order to better define changes in individual OTUs, Metastats [23] was used to identify OTUs 
that were significantly altered (P £ 0.05) by each AGP relative to the control group. Overall, 898 
OTUs were significantly up- or down-regulated by at least one AGP, with 59 of those affected by 
all five AGPs (Figure 4). The majority of these were observed to be rare OTUs belonging to a 
diverse set of bacterial genera (data not shown). Apparently, each AGP also showed an obvious 
differential effect, with a group of OTUs being uniquely modulated by individual AGPs (Figure 
4). Additionally, monensin and salinomycin supplementation resulted in a depletion of a number 
of lowly abundant OTUs belonging to unclassified genera of Ruminococcaceae and Clostridiales 
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(data not shown), consistent with a significant decrease in microbiota richness in the α-diversity 
analysis. 
Among the top 100 most abundant OTUs, 64 were significantly affected by at least one 
treatment as revealed by Metastats and visualized in a heatmap (Figure 5). It is obvious that each 
AGP regulate different bacterial populations in the cecum. For example, a unclassified member of 
Ruminococcaceae (OTU0085) was significantly increased by BMD, but remained largely 
unchanged in response to other AGPs; on the other hand, another unclassified Ruminococcaceae 
(OTU0003) was significantly suppressed by monensin, but not other AGPs (Figure 5). However, 
several OTUs were regulated similarly in response to all five AGPs. For example, an 
Escherichia/Shigella member (OTU0021), a Blautia member (OTU0016), a Clostridium XlVa 
member (OTU0039), and an unclassified member of Clostridiales (OTU0059) were enriched by 
all five AGPs, whereas a Clostridium XIVb member (OTU0073) and a Lactobacillus (OTU0019) 
were decreased by all AGPs (Figure 5). Relative abundances of OTU0039 in the cecum of 
individual broilers were further illustrated in a dot plot (Figure 6A). It is not surprising that 
Euclidean clustering identified a clear segregation of five AGPs, with three antibiotics forming 
one clade and two ionophores forming the other (Figure 5). A cluster of four members of 
Firmicutes (OTU0047, OTU0070, OTU0080, and OTU0092) were clearly suppressed by two 
ionophores, but largely unaffected by three antibiotics (Figure 5 and Figure 6B). A 
Streptococccus member (OTU0052) was also significantly suppressed by two ionophores, but 
dramatically enriched by tylosin, while two other antibiotics had no effect (Figure 5 and Figure 
6C). Conversely, an Enterococcus (OTU0081) was significantly enriched by two ionophores, but 
unaffected by antibiotics (Figure 6D). Within the antibiotics clade, tylosin and virginiamycin 
were shown to cluster separately from BMD, consistent with their differences in antimicrobial 
mechanism and spectrum [2,17]. A cluster of six OTUs (OTU0023, OTU0026, OTU0060, 
OTU0084, OTU0088, and OTU0098) and another cluster of two OTUs (OTU0054 and 
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OTU0058) were uniquely suppressed by BMD, with no obvious effect by other antibiotics 
(Figure 5) as exemplified by OTU0023 (Figure 6E).  
Discussion 
In-feed AGPs are known to modulate gut microbiota. Early culture-independent studies using 
molecular techniques such as terminal restriction fragment length polymorphism, denaturing 
gradient gel electrophoresis, and Sanger sequencing of the 16S rRNA gene clone libraries 
revealed a consistent and obvious antibiotic-induced shift in the microbiota composition 
[26,27,28,29,30,31]. However, these techniques lack the depth and precision to reveal specific 
changes in bacterial taxa. Subsequent next-generation sequencing of the bacterial 16S rRNA gene 
demonstrated specific changes in certain bacterial populations, but with largely inconsistent 
results. Multiple studies have shown no obvious effect of antibiotics on α-diversity [32,33,34,35], 
while others showed a decrease [36,37] or an increase in α-diversity of the cecal microbiota [38]. 
Significant changes in bacterial composition, measured by β-diversity, were observed more 
consistently [34,37,38,39], with only a few studies not reporting a shift [36,40]. However, very 
few studies compared the impact of multiple AGPs, particularly antibiotics and ionophores, on 
the gut microbiota side-by-side.  
In this study, two-week supplementation with three classical antibiotics (BMD, tylosin, 
and virginiamycin) had a minimum effect on α- or β-diversity of the chicken cecal microbiota. 
Surprisingly, a significant decrease in richness and a concurrent increase in evenness of the cecal 
microbiota was observed for two ionophores (monensin and salinomycin), consistent with the 
16S rRNA gene sequencing results showing a significant diminishment of a large number of rare 
bacterial phylotypes. Previous work investigating the effects of ionophores on poultry microbiota 
is limited. However, Danzeisen et al. [32] reported a similar, though non-significant, decrease in 
α-diversity of the cecal microbiota in broilers in response to monensin supplementation.  
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Overall, the most dramatic effect of AGP supplementation is differential enrichment of the 
Clostridiales order, particularly the members of three most dominant bacterial families in the 
chicken cecum (Ruminococcaceae, Lachnospiraceae, and Clostridiaceae) [41]. Among the 100 
most abundant bacterial taxa, a number of the Ruminococcaceae members were enriched in the 
cecum by AGPs, while many Lachnospiraceae species appear to be diminished (Figure 5). 
Previous studies have found both Ruminococcaceae and Lachnospiraceae to be increased 
following supplementation of broiler diets with a mixture of chlortetracycline, virginiamycin, and 
amoxicillin [42], but decreased by avilamycin, flavophospholipol, or zinc bacitracin [36,43]. Both 
Ruminococcaceae and Lachnospiraceae are known to produce butyrate [44,45]. It is noted that 
several Clostridium IV and XIVa members such as OTU0039, OTU0075, and OTU0076 were 
also significantly increased in abundance. Both IV and XIVa clusters of Clostridia are the two 
most dominant bacterial taxa in the hind gut of humans and well-known for their ability to 
produce butyrate from indigestible carbohydrates [46,47]. These results are consistent with earlier 
observations that in-feed antibiotics preferentially enriched butyrate-producing bacteria [42]. 
Lactic acid bacteria are widely used as probiotics to provide a myriad of beneficial effects 
to the host [48,49]. Only three lactic acid bacterial genera including Enterococcus, Lactobacillus, 
and Streptococcus were differentially regulated by AGPs among the 100 most abundant OTUs in 
the cecum. It is interesting to note that all three Enterococcus members (OTU0081, OTU0090, 
and OTU0094) were upregulated by AGPs, while the only Lactobacillus member (OTU0019) 
was obviously reduced in response to all but one AGPs. A reduction in the Lactobacillus 
abundance is consistent with earlier observations that AGP administration was associated with 
depopulation of the Lactobacillus species [50,51], resulting in reduced bile salt deconjugation and 
improved fat digestion and utilization [51]. Lactobacilli are known to be major producers of bile 
salt hydrolase responsible for hydrolyzing and deconjugating primary bile acids [52]. A lone 
Streptococcus member (OTU0052) was significantly reduced by two ionophores, but 
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significantly enriched by tylosin, while BMD and virginiamycin had a minimum impact. 
Streptococcus has been shown to be suppressed by carbadox and a mixture of three antibiotics 
(chlortetracycline, sulfamethazine, and penicillin) in pigs [53] or a mixture of three different 
antibiotics (amoxicillin, metronidazole, and bismuth) in mice [54]. 
These results collectively suggest that AGPs have a strong tendency to enrich butyrate- 
and lactic acid-producing bacteria, while reducing bile salt hydrolase-producing bacteria, in the 
cecum. A combination of these effects leads to enhanced metabolism and utilization of dietary 
carbohydrates and lipids and improved energy harvest and mucosal immune defense, all of which 
may be responsible for the growth-promoting effect of AGPs. 
Among five AGPs selected for this study, BMD kills a broad spectrum of Gram-positive 
bacteria by interfering with synthesis of bacterial cell wall and peptidoglycan, while tylosin and 
virginiamycin act against a narrower spectrum of Gram-positive bacteria via inhibition of 
bacterial protein synthesis [17]. Two ionophores (monensin and salinomycin), on the other hand, 
kill bacteria and parasites by facilitating transportation of monovalent ions and thereby disrupting 
ion gradients across cell membranes, although monensin preferentially transports Na+ and H+, 
while salinomycin prefers K+ and Na+ [17,55]. An obvious differential effect exists among 
individual AGPs and among different classes of AGPs, although a number of bacteria are 
commonly regulated by all AGPs. It is apparent that, the larger the difference in the antibacterial 
spectrum and mode of action among AGPs, the more distinct the bacterial populations that they 
regulate. We observed that monensin and salinomycin modulate similar bacterial populations that 
are rather different from three antibiotics. Among three antibiotics, virginiamycin and tylosin 
were found to manipulate the microbiota composition in a more similar manner than BMD.  
Among top 100 OTUs, 97 belong to Firmicutes. The only Bacteroides (OTU0037) was 
obviously enriched by BMD and salinomycin, but suppressed by tylosin and monensin. Such a 
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differential regulation pattern is interesting, but the reason is currently unknown, although 
Bacteroides, with the ability to degrade non-digestible carbohydrates to produce short-chain fatty 
acids [56,57], was reported to be enriched by BMD [38]. A lone Proteobacteria 
(Escherichia/Shigella OTU0021) was also enriched by all five AGPs, which is in agreement of 
earlier reports that a transient upregulation of Escherichia/Shigella in response to in-feed 
antibiotics [53,54]. 
It is important to note that closely related bacteria within a genus are not necessarily 
regulated in the same fashion even by the same AGP. For example, multiple clusters of the 
Clostridium genus were differentially regulated. One abundant member of Butyricicoccus 
(OTU0010) was enriched by AGPs, but a less abundant Butyricicoccus (OTU0080) was 
diminished particularly by ionophores. While Blautia OTU0016 is upregulated, Blautia 
OTU0017 and OTU0070 are downregulated by AGPs. It is, therefore, difficult to predict the net 
outcome in the abundance of certain bacterial populations. Future studies to perform absolute 
quantification of individual bacterial taxa will help provide a more definitive answer to the net 
change in each bacterial population.  
In this study, we demonstrated the differential effects of five different AGPs on the cecal 
microbiome of broiler chickens. While each treatment displayed certain effect on cecal 
microbiome composition, the most drastic changes were observed with ionophores. Investigation 
into the regulation of specific OTUs revealed an enrichment of beneficial bacteria following 
antimicrobial treatment, particularly in OTUs involved in butyrate synthesis. However, we only 
examined the cecal microbiota changes two weeks after AGP supplementation. It will be 
beneficial to investigate the kinetic response of the gut microbiota in response to AGPs, revealing 
whether certain bacterial populations undergo temporal or persistent alterations. Furthermore, 
because the small intestine is the major site where most nutrients are digested and absorbed, 
studying the microbiota changes in the small intestine by AGPs is also warranted.  
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Although different AGPs appear to shift the structure of gut microbiota in distinct 
manners, it will be important to examine how the function of gut microbiota is altered by AGPs, 
which can be evaluated by using a combination of metagenomics, metabolomics, 
metatranscriptomics, and/or metaproteomics. It is tempting to speculate that, regardless of the 
antimicrobial spectrum and mode of action, AGPs improve growth performance by enhancing the 
functional potential of the gut microbiota resulting in more efficient digestion and utilization of 
dietary carbohydrates and lipids in the gastrointestinal tract. 
In summary, our data indicates an ability of AGPs to modulate cecal microbiota to allow 
an increase in the bacteria associated with improved digestion and energy utilization. A better 
understanding of the mechanism by which AGPs modulate gut microbiota and enhance growth in 
livestock animals will lead to the development of effective antibiotic alternatives that mimic the 
action of AGPs. 
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Table 5.1. ANOSIM analysis of different antimicrobials on β-diversity of the cecal microbiota. 
 Control BMD Tylosin Virginiamycin Monensin Salinomycyin 
Control  P = 0.043 R = 0.071  
P = 0.052 
R = 0.061 
P = 0.036 
R = 0.090 
P < 0.001 
R = 0.921 
P < 0.001 
R = 0.809 
BMD P = 0.013 1 
R = 0.145   
 P = 0.243 
R = 0.021 
P = 0.043 
R = 0.095 
P < 0.001 
R = 0.914 
P < 0.001 
R = 0.774  
Tylosin P = 0.009 
R = 0.149 
P = 0.004 
R = 0.187 
 P = 0.595 
R = 0.015 
P < 0.001 
R = 0.855 
P < 0.001 
R = 0.714  
Virginiamycin P = 0.001 
R = 0.226 
P = 0.009 
R = 0.164 
P = 0.197 
R = 0.048 
 P < 0.001 
R = 0.957 
P < 0.001 
R = 0.832 
Monensin P < 0.001 
R = 0.315 
P < 0.001 
R = 0.284 
P < 0.001 
R = 0.411 
P < 0.001 
R = 0.401 
 P = 0.021 
R = 0.076 
Salinomycin P = 0.002 
R = 0.163 
P = 0.003 
R = 0.205 
P < 0.001 
R = 0.294 
P < 0.001 
R = 0.292 
P = 0.029 
R = 0.105 
 












Fig. 5.1. The α-diversity of cecal microbiota of broilers following 2-week supplementation of 
different antimicrobials. Changes in evenness and richness were calculated from 12 samples of 
each treatment using the Shannon evenness index (A) and Observed OTUs (B), respectively. Data 
from three antibiotics and two ionophore groups were further combined separately and the 
Shannon evenness index (C) and Observed OTUs (D) were recalculated. One-way ANOVA with 
post hoc Tukey’s test was performed, with the treatments not sharing a common superscript 







Fig. 5.2. The β-diversity of cecal microbiota of broilers following 2-week supplementation of 
different antimicrobials. Principal coordinate analysis (PCoA) plots were generated from 12 
samples of each treatment using Bray-Curtis (A) and Jaccard indices (B), respectively. Statistical 





Fig. 5.3. Differences in cecal microbiota composition of broilers following 2-week 
supplementation of different antimicrobials. Relative abundance of OTUs were calculated and 
plotted at the phylum and genus (A) levels. Three antibiotics and two ionophore groups were 
further combined separately and relative abundance of OTUs were recalculated and plotted at the 
phylum and genus levels (B). All antimicrobial groups were combined and compared with the 
control group at the phylum and genus levels (C). Only the top three phyla and top 10 genera are 




Fig. 5.4. Differential enrichment of OTUs by in-feed antimicrobials. Significant up- or down-
regulation of OTUs was determined using Metastats [23], relative to the control group (P £ 0.05). 





Fig. 5.5. Differential regulation of the top 100 OTUs by in-feed antimicrobials. Among top 
100 OTUs, 64 were significantly affected by at least one antimicrobial and thus plotted using 
Heatmapper [25]. Fold change was calculated as the mean relative abundance of an OTU in an 
antimicrobial group relative to that in the control, followed by log2 transformation for 





Fig. 6.6. Differential regulation of representative bacteria taxa by in-feed antimicrobials. 
Each group consists of 12 cecal samples. For OTU0052, three outliers (relative abundance > 3%) 
were omitted for better visualization of final differences among group. Statistical significance 
was determined using Metastats [23], with the treatments not sharing a common letter considered 







Biogeographical distribution and succession of the intestinal mycobiota of broiler chickens were 
successfully characterized throughout an entire production cycle, and the response of the 
intestinal mycobiota to an in-feed antibiotic was also investigated. The mycobiome was revealed 
to be relatively stable with the majority of sequences belonging to the phyla Ascomycota and 
Basidiomycota regardless of GI location or age. The most abundant genera wer Microascus, 
Gibberella, Trichosporon, Aspergillus, and Candida. However, the most abundant genera 
differed between studies. Feature-level analysis revealed a clear succession of the mycobiome 
through the GI tract as birds aged, while BMD supplementation produced a clear change in cecal 
composition at 14 days of age.  
Evaluation of the effect of five subtherapeutic antibiotics on cecal microbiota 
composition after 14 days of supplementation revealed a clear modulation of the bacterial 
community with each treatment resulting in a unique bacterial profile. Of note is the observation 
that ionophores caused a significant decrease in the number of rare bacterial species resulting in a 
decrease in microbiota richness and increase in evenness. Investigation into microbes 
significantly affected by each treatment revealed an overall increase in bacteria associated with 
improved digestion and energy utilization. 
 
This dissertation has successfully laid the foundation for future work regarding 
manipulation of the intestinal microbiota as a novel antibiotic-free strategy to disease control and 
prevention. As the main fungal genera in both studies differed significantly and are known to be 
associated with feed ingredients and environmental factors, it will be important to determine the 
source of intestinal fungi. Additionally, the role of intestinal fungi in disease can be elucidated in 
a chicken disease models such as necrotic enteritis and coccidiosis. It is our expectation that these 
studies will lead to the identification of microbial species associated with improved growth 
performance and disease resistance. These will then be further assessed for their potential to be 
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